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ABSTRACT 
 
IDENTIFICATION OF 
VERY LOW DENSITY LIPOPROTEIN RECEPTOR (VLDLR) MUTATIONS 
IN CEREBELLAR HYPOPLASIA AND QUADRUPEDAL LOCOMOTION 
(UNERTAN SYNDROME) IN HUMANS 
 
 
ġafak Çağlayan 
M.S in Molecular Biology and Genetics 
Supervisor: Prof. Tayfun Özçelik 
July 2008, 134 Pages 
 
 
 
Cerebellar hypoplasia and quadrupedal locomotion in humans, also known as Unertan 
syndrome, is a severe neurodevelopmental condition accompanied by dysarthria and 
impaired cognitive skills. The molecular underpinnings of development of the brain 
structures required for bipedal gait in humans can be established through identification 
of the gene(s) associated with this disorder. Four consanguineous families from Turkey 
exhibiting this autosomal recessive trait were studied. In two families (A and D), 
affected individuals shared homozygosity in a critical 1.032-Mb region in chromosome 
9p24. Sequence analysis linked the disease to two distinct mutations in the very low 
density lipoprotein receptor (VLDLR) gene; the nonsense change R257X in family A 
and the single nucleotide deletion leading to frameshift I780TfsX3 in family D. VLDL 
receptor is a co-receptor of reelin molecule. Reelin signaling pathway is involved in 
neuronal migration and lamination to form brain cortices during embryonic 
development. Mutant VLDL receptors are truncated proteins that cannot be inserted 
into the membrane. Homozygosity mapping linked the disease locus in family B to 
chromosome 17p13. Family C does not share homozygosity in neither of the loci. 
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ÖZET 
 
ĠNSANDA SEREBELLAR HĠPOPLAZĠ VE QUADRUPEDAL YÜRÜMEDE  
(ÜNERTAN SENDROMU) DÜġÜK YOĞUNLUKLU LĠPOPROTEĠN 
RESEPTÖRÜ (VLDLR) MUTASYONLARININ TESPĠT EDĠLMESĠ 
 
 
ġafak Çağlayan 
Moleküler Biyoloji ve Genetik Yüksek Lisans 
DanıĢman: Prof. Tayfun Özçelik 
Temmuz 2008, 134 Sayfa 
 
 
 
Serebellar hipoplazi ve quadrupedal yürüme şiddetli bir nörogelişimsel hastalıktır. 
Unertan sendromu olarak da bilinen bu duruma disartirik konuşma ve zeka geriliği 
eşlik etmektedir. İnsanda bipedal yürüme için gerekli beyin yapılarının gelişmesinin 
moleküler temelleri, bu bozukluğa yol açan gen(ler)in bulunması ile kurulabilir. 
Çalışmada, otozomal resesif hastalığı taşıyan Türkiye’deki dört akraba aile 
incelenmiştir. Ailelerin ikisinde (A ve D), hasta bireyler 9p24 kromozomunda     
1.032-Mb büyüklüğündeki bir kritik bölgede homozigosite göstermektedirler. Dizi 
analizi, hastalığı düşük yoğunluklu lipoprotein reseptörü (VLDLR) genindeki iki farklı 
mutasyona bağlamıştır; A ailesindeki R257X anlamsız değişim ve D ailesindeki 
I780TfsX3 çerçeve kaymasına yol açan tek nükleotidlik delesyon. VLDL reseptörü 
reelin molekülünün reseptörlerinden birisidir. Reelin sinyal yolağı embriyonik gelişim 
sürecinde beyin korteksinin oluşması için nöronların taşınmasında ve 
tabakalanmasında rol oynamaktadır. Mutant VLDL reseptörleri hücre zarına 
eklenemeyecek kesik proteinler olarak oluşmaktadırlar. Homozigosite haritalaması B 
ailesindeki hastalık bölgesini 17p13 kromozomuna bağlamıştır. C ailesi iki bölgenin 
hiçbirisi ile homozigosite paylaşmamaktadır.  
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PART I: INTRODUCTION 
 
 
 
1.1 Quadrupedal Locomotion in Humans: Unertan Syndrome 
This unique phenotype was first described by Prof. Uner Tan in a 
consanguineous family living in southern Turkey. Non-progressive cerebellar 
hypoplasia, quadrupedal locomotion, dysarthric speech and mental retardation are 
the hallmarks of this condition, which is named as Unertan syndrome based on the 
name of discoverer (Tan, 2005).  
1.1.1 Families described in Turkey 
Initially we studied family A, a consanguineous kindred living in 
southeast region of Turkey (Figure 1.1). There are seven affected individuals in 
this family. All affected individuals walk quadrupedally. There is one girl who 
can walk bipedally, but she prefers quadrupedal locomotion. Other main features 
of the affected individuals are cerebellar hypoplasia, impaired cognitive skills, 
and primitive language (Tan et al., 2008a; Ozcelik et al., 2008a). 
Family B is the first identified family (Figure 1.2). Five of 19 children 
walk in a quadrupedal fashion. Two children using bipedal locomotion have a 
neurological phenotype similar to that of their quadruped siblings (Tan, 2005; 
Turkmen et al., 2006).  
Another family exhibiting Unertan syndrome is family C residing in 
southern Turkey (Figure 1.3). There are four affected individuals and two of them 
ambulate quadrupedally. One of the remaining two is a biped ataxic man who was 
a quadruped during childhood, and the other patient, who was also a quadruped, is 
no longer able to ambulate now (Tan, 2006b). 
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Figure 1.1 Pedigree of family A residing in southeastern Turkey. Filled symbols represent the affected individuals. Squares indicate 
males, and circles indicate females. All affected individuals are resulting from consanguineous marriages.  
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Figure 1.2 Pedigree of family B. Parents of the affected children are second cousins. Two children, who use bipedal locomotion, but 
have a neurological phenotype similar to that of their quadruped siblings are shown with gray symbols.
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Figure 1.3 Pedigree of family C. Pedigree analysis show consanguineous matings in the family.
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Family D was encountered during the course of our studies (Figure 1.4). 
This consanguineous family is from western Turkey and all of the three affected 
individuals are quadrupeds (Tan, 2008b; Ozcelik et al., 2008a). 
  
 
Figure 1.4 Pedigree of family D.  
 
1.2 Ataxia 
The word ataxia means “absence or loss of order” and the term ataxia is 
generally used to describe uncoordinated walking.  Actually, ataxia is neither a 
specific disease nor a disorder.  It is a set of symptoms affecting coordination of 
gait, speech (dysarthria), hands, arms, and eye movements (nystagmus).  
Atrophy of cells in the cerebellum or its connections, diseases causing 
cerebellar or spinocerebellar degeneration, or damages to cerebellar/spinal 
structures are the most common causes of ataxia.  
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There are several medical and neurological conditions that can lead to 
ataxia. According to the National Ataxia Foundation of the USA, ataxia can 
appear in people suddenly as a result of one or more of these conditions: head 
trauma, stroke, brain hemorrhage, brain tumor, congenital abnormality, severe 
viral infection, exposure to certain drugs or toxins (i.e. alcohol, anti-convulsive 
medicines), cardiac or respiratory arrest. Additionally there are several conditions 
that may result in ataxia over time. These are hypothyroidism, deficiencies of 
certain vitamins (E, B12), exposure to certain drugs or toxins (heavy metals, anti-
convulsive medicines, chronic alcohol exposure, and certain cancer drugs), 
congenital abnormality, multiple sclerosis, syphilis (locomotor ataxia), hereditary 
disorders, idiopathic (unknown cause) cerebellar degeneration disorders (Official 
website of the National Ataxia Foundation of the USA; http://www.ataxia.org/).  
Cerebellar/spinocerebellar syndromes are a heterogenous group of 
neurological disorders causing ataxia. Patients with spinocerebellar syndromes 
exhibit classical ataxia features like disequilibrium, progressive incoordination of 
gait and limbs, and speech and eye movement disturbances. Other neurological 
symptoms including pyramidal or extrapyramidal signs, spasticity, 
ophthalmoplegia, and dementia can be also found in patients (Mariotti & Di 
Donato, 2001).  
Ataxic individuals can display different symptoms and severity of the 
disease can be variable among patients. Because of this variability in phenotypes 
and neuropathological findings, making a proper clinical classification and 
differential diagnosis is very difficult. Nevertheless, certain types of ataxias can 
be differentiated with the help of additional specific symptoms.  Also other 
affected family members can be useful in diagnosis in the case of hereditary 
ataxias. Hence, spinocerebellar syndromes can be distinguished into two forms: 1) 
sporadic ataxias of unknown cause or that are acquired due to associated illness 
and 2) inherited spinocerebellar ataxias (Mariotti & Di Donato, 2001). 
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It is a challenging task for clinicians to diagnose sporadic ataxia since they 
should rule out every possibility of hereditary ataxia before making a final 
diagnosis. Phenotypes with multiple system atrophy are the major group in the set 
of sporadic spinocerebellar syndromes of unknown cause. Acquired or non-
hereditary spinocerebellar syndromes can be due to certain environmental factors 
including alcoholism or vitamin deficiencies. Multiple sclerosis, vascular 
diseases, and tumors or paraneoplastic syndromes can also cause cerebellar 
ataxias (Table 1.1) (Mariotti & Di Donato, 2001). Conditions resulting in sporadic 
ataxia can affect only the cerebellum (“pure cerebellar” form) or they can cause 
additional symptoms such as neuropathy (dysfunction of the peripheral nerves), 
dementia (impaired intellectual function), weakness, rigidity, or spasticity of the 
muscles (“cerebellar plus” form) (Official website of the National Ataxia 
Foundation of the USA; http://www.ataxia.org/). 
 
Table 1.1 Sporadic spinocerebellar syndromes. (Mariotti & Di Donato, 2001) 
Unknown causes 
Multiple system atrophy  
     Olivopontocerebellar atrophy  
     Striatonigral degeneration  
     Shy-Drager syndrome 
 
Immune 
Multiple sclerosis 
Glutamic acid decarboxylase antibody 
Paraneoplastic syndromes 
 
Systemic diseases 
Celiac diseases 
Vitamin E malaabsorption 
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Hereditary ataxias are neurological disorders caused by a defect in a 
certain gene that is inherited through families. This group of diseases is 
characterized by progressive degeneration of the cerebellum and spinocerebellar 
tracts of the spinal cord accompanied by various pathologies in central and 
peripheral nervous systems (Di Donato et al., 2001).  
Since clinical phenotypes of different genotypes of inherited ataxias show 
significant overlap, it is difficult to make a classification based on clinical or 
histopathological findings (Banfi & Zoghbi, 1994). So, it is more useful to divide 
hereditary cerebellar/spinocerebellar syndromes according to the inheritance mode 
as autosomal dominant, autosomal recessive, X-linked and mitochondrial 
disorders (Mariotti & Di Donato, 2001).  
There is no specific treatment for directly curing diseases that cause ataxia. 
Aims of therapies are generally to diminish the severity of symptoms. For 
example if ataxia is due to a stroke, vitamin deficiency, or exposure to a toxic 
drugs or chemicals, then treatment would target specific ailment. Physical therapy 
is a widely used option for people with impaired gait. Furthermore, ataxic 
individuals can use adaptive devices (i.e. a cane, crutches, walker, or wheelchair 
to help for walking; devices to assist feeding, and self cares for patients having 
difficulties in hand and arm coordination; and communication devices if speech is 
impaired) to be able to live independently. 
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1.2.1 Autosomal dominant ataxias 
Autosomal dominant cerebellar/spinocerebellar ataxias are a complex 
group of neurodegenerative diseases. These disorders are clinically heterogeneous 
since affected individuals exhibit several overlapping neurological symptoms. 
These symptoms include loss of balance and motor coordination, dysarthric 
speech, ophthalmoplegia, pyramidal and extrapyramidal signs, dementia, 
pigmentary neuropathy, peripheral neuropathy, oculomotor disturbances of 
cerebellar and supranuclear genesis, retinopathy, optic atrophy, spasticity, 
sphincter disturbances, cognitive impairment, and epilepsy (Duenas et al., 2006; 
Zoghbi, 2000; Schols et al., 2004).  
The prevalence of the autosomal dominant ataxias is assumed as three 
cases per 100,000 individuals, although real number can be higher. Different 
ethnic and continental populations show diverse prevalence rates for specific 
types because of heterogeneity of the disorders (Schols et al., 2004). Onset of 
ataxia symptoms is generally between 30 and 50 years of age. However, there are 
individuals with disease onset in childhood or at later decades after 60 years 
(Duenas et al., 2006). 
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Disease onset in adulthood, occurrence of anticipation (disease onset 
becomes at earlier ages and disease become more severe in successive 
generations) and atrophy of cerebellum are common clinical features of autosomal 
dominant ataxias. Nonetheless, variable and unpredictable association of signs of 
central nervous system and peripheral nervous system can accompany common 
symptoms. Because of this, clinical classification is complicated. Yet, autosomal 
dominant ataxias have been divided into three groups based on clinical findings: 
ADCA (Autosomal dominant cerebellar ataxia) I, ADCA II and ADCA III 
(Harding, 1993; Duenas et al., 2006). This type of classification and diagnosis is 
especially useful for patient management.  
 
On the other hand identification of genetic basis of most of these disorders 
have had a significant impact on nosology, diagnostic procedures and the 
management of patients. It led to the development of a new classification system 
based on molecular genetic data, and improvements in diagnosis and patient 
management (Di Donato, 1998). In this systematic, autosomal dominant ataxias 
are distinguished into 29 defined subtypes, of which the causative genes and 
pathogenic mutations are known in 15 (Table 1.2) (Duenas et al., 2006, Schols et 
al., 2004). Molecular genetics approaches have revealed that the main pathogenic 
mechanisms of these disorders include abnormal proteins or RNAs, which “gain a 
toxic function”, and lead to neuronal and systemic dysfunction (Gatchel & 
Zoghbi, 2005; Orr & Zoghbi, 2007). 
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Table 1.2 Summary of the molecular features of spinocerebellar ataxias. 
 (Duenas et al., 2006) 
SCA subtype Genomic location Gene/locus Protein Mutation 
SCA1 6p23 ATXN1 Ataxin 1 CAG repeat 
SCA2 12q24 ATXN2 Ataxin 2 CAG repeat 
SCA3 14q24.3-q31 ATXN3 Ataxin 3 CAG repeat 
SCA4 16q24-qter SCA4 U U 
SCA5 11q13 SPTBN2 Beta-III spectrin D, MM 
SCA6 19p13 CACNAIA CACNAIA CAG repeat 
SCA7 3p21.1-p12 ATXN7 Ataxin 7 CAG repeat 
SCA8 13q21 KLHLIAS Kelch-like I CTG repeat 
SCA9 Reserved U U U 
SCA10 22q13 ATXN10 Ataxin 10 ATTCT repeat 
SCA11 15q15.2 TTBK2 TTBK2 D, I 
SCA12 5q31-q33 PPP2R2B PPP2R2B CAG repeat 
SCA13 19q13.3-q13.4 KCNC3 KCNC3 MM 
SCA14 19q13.4 PRKCG PRKCG MM 
SCA15 3p24.2-pter U U U 
SCA16 8q23-q24.1 U U U 
SCA17 6q27 TBP TBP CAG repeat 
SCA18 7q22-q32 U U U 
SCA19* 1p21-q21 U U U 
SCA20 11p13-q11 U U U 
SCA21 7p21.3-p15.1 U U U 
SCA22* 1p21-q23 U U U 
SCA23 20p13-p12.3 U U U 
SCA24 1p36 U U U 
SCA25 2p21-p13 U U U 
SCA26 19p13.3 U U U 
SCA27 13q34 FGF14 FGF14 MM 
SCA28 18p11.22-q11.2 U U U 
SCA29 3p26 U U U 
DRPLA 12p13.31 ATN1 Atrophin 1 CAG repeat 
     
Undefined** 16q22.1 PLEKHG4 Puratrophin 1 5’SNS 
 
* SCAs 19 and 21 are likely allelic forms of the same gene. 
** The gene encoding Puratrophin 1 lies on the same chromosomal region where 
the SCA4 gene localizes.  
Genes in genomic location are noted according to Ensembl. D, deletions; I, 
insertions; MM, missense mutations; SCA, spinocerebellar ataxia; SNS, single-
nucleotide substitutions; U, unknown. 
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1.2.2 Autosomal recessive ataxias 
Autosomal recessive ataxias are a group of rare and clinically 
heterogeneous neurological diseases. The most important symptom of these 
disorders is spinocerebellar ataxia, involving the cerebellum, brainstem, or 
spinocerebellar long tracts. Patients exhibit poor balance with falls, imprecise 
hand coordination, postural or kinetic tremor of the extremities or trunk, 
dysarthria, dysphagia, vertigo, and diplopia (Perlman, 2004). Various neurologic, 
ophthalmologic and systemic pathologies affecting both central and peripheral 
nervous system, and in some cases other systems and organs can accompany 
ataxia (Palau & Espinos, 2006).  
These phenotypic features can be so rare. Yet, they are important to make 
a differential diagnosis and to decide on further therapies. Moreover, since these 
disorders are clinically heterogeneous, detailed assessments and additional 
diagnostic studies (i.e. neuroimaging or electrophysiological examinations) are 
required to make a proper differentiation. For example atrophy of cerebellum is a 
useful distinguishing feature and neuroimaging can be particularly useful to 
confirm clinical findings. Performing genetic tests/mutation analysis in diagnosis 
is also possible for the diseases for which causative genes were identified (Di 
Donato et al., 2001; Fogel & Perlman, 2007). Ataxia associated with deficiency of 
coenzyme Q10 and abetalipoproteinemia are the only types of recessive ataxias 
that have specific treatments (Espinos-Armero et al., 2005). 
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Until recent years characterization of autosomal recessive ataxias 
remained poor when compared to dominant ataxias. Several conditions have been 
genetically described in the last few years. It has been found that most of the 
recessive ataxias are associated with a “loss of function” of specific cellular 
proteins involved in metabolic homeostasis, cell cycle, and DNA repair/protection 
processing (Di Donato et al., 2001). Generally each disease of this group is 
caused by defect(s) in a specific gene. Nonetheless, some recessive ataxias are 
genetically heterogeneous and can be caused by mutation(s) in more than one 
gene (Palau & Espinos, 2006). 
The prevalence of autosomal recessive cerebellar ataxias has been 
estimated to be 7 in 100,000 individuals (Espinos-Armero et al., 2005). Among a 
large number of rare recessive disorders, Freidriech ataxia is the most common 
type in Caucasian populations (estimated prevalence is 2-4 cases in 100,000). 
Other frequent types include ataxia telangiectasia (1-2.5/100,000) and early onset 
cerebellar ataxia with retained tendon reflexes (1/100,000) (Palau & Espinos, 
2006). Remaining types are much rare and prevalence of some can be variable 
among different regions (Di Donato et al., 2001). For most of the autosomal 
recessive ataxias disease onset is before age 20 years (Fogel & Perlman 2007). 
Based on pathogenic mechanisms five main types of autosomal recessive 
ataxias can be distinguished: 1) congenital (developmental disorder); 2) ataxias 
associated with metabolic disorders including ataxias caused by enzymatic 
defects; 3) ataxias due to DNA repair defects; 4) degenerative and progressive 
ataxias that include ataxias with known cause and pathogenesis (such as Friedrich 
ataxia), and ataxias of unknown etiology; 5) ataxias associated with 
other/additional features (Table 1.3) (Espinos-Armero et al., 2005; Palau & 
Espinos, 2006). 
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Table1.3 Summary of the molecular features of autosomal recessive ataxias   
(Palau & Espinos, 2006) 
 Protein (Gene or Locus) Location 
Congenital ataxias   
Joubert syndrome   
     JBTS 1 (cerebelloparenchymal disorder IV, CPD IV) U 9q34.3 
     JBTS 2 (CORS2) U 11p12-q13.3 
     JBTS 3 AHI1 6q23.3 
     JBTS 4 (nephronophthisis 1) NPHP1 2q13 
     JBTS 5 CEP290 or NPHP6 12q21.3 
     JBTS 6 TMEM67 8q21.13-q22.1 
     JBTS 7 RPGRIP1L 16q12.2 
Cayman ataxia Cayataxin (ATCAY) 19p13.3 
   
Metabolic ataxias   
Ataxia with isolated vitamin E deficiency (AVED) α-TTP (TTPA) 8q13.1-q13.3 
Abetalipoproteinemia MTP 4q22-q24 
Cerebrotendinous xanthomatosis CYP27A1 2q33-qter 
Refsum disease PAHX or PHYH 10pter-p11.2 
 PEX7 6q22-q24 
   
DNA repair defects   
Ataxia telangiectasia ATM 11q22.3 
Ataxia with oculomotor apraxia 1 (AOA 1) Aprataxin (APTX) 9p13.3 
Ataxia with oculomotor apraxia 2 (AOA 2) or SCAR1 Senataxin (SETX) 9q34 
Ataxia telangiectasia-like disorder (ATLD) MRE11A 11q21 
Spinocerebellar ataxia with axonal neuropathy (SCAN1) TDP1 14q31-q32 
Xeroderma pigmentosum (XP) NPHP6 12q21.32 
     XP of complementation group A     XPA 9q22.3 
     XP of complementation group B     XPB/ERCC3 2q21 
     XP of complementation group C     XPC 3p25 
     XP of complementation group D     XPD/ERCC2 19q13.2-q13.3 
     XP of complementation group E     XPE (DDB2) 11p12-p11 
     XP of complementation group F     XPF/ERCC4 16p13.3-p13.13 
     XP of complementation group G     XPG/ERCC5 13q33 
     XP variant (XPV) or XP with normal DNA repair rates     POLH 6p21.1-p12 
Degenerative ataxias   
Friedrich ataxia Frataxin (FRDA) 9q13 
Mitochondrial recessive ataxic syndrome (MIRAS) Polymerase γ (POLG) 15q25 
Charlevoix-Saguenay spastic ataxia Sacsin (SACS) 13q12 
Early onset cerebellar ataxia with retained tendon reflexes 
(EOCARR)  13q11-q12 
Infantile onset spinocerebellar ataxia (IOSCA) Twinkle (C10ORF2) 10q24 
Marinesco-Sjögren syndrome(MSS)    
     Classical MSS SIL1 5q31 
     MSS with myoglobinuria CTDP1 18qter 
Coenzyme Q10 deficiency with cerebellar ataxia ?  
Posterior column ataxia and retinis pigmentosa (PCARP) AXPC1 1q31 
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1.2.3 X-linked ataxias 
X-linked ataxias are a group of rare and poorly characterized disorders. 
Relatively well described diseases in this group include fragile X tremor/ataxia 
syndrome, which is caused by an RNA gain-of-function-based mechanism (Orr & 
Zoghbi, 2007), and sideroblastic anemia with spinocerebellar ataxia (Table 1.4). 
 
Table 1.4 Summary of the molecular features of X-linked ataxias 
Disease Genomic location Gene/locus Protein Mutation 
SCAX1 Xp11.21-q21.3 U U U 
SCAX2 U U U U 
SCAX3 U U U U 
SCAX4 U U U U 
SCAX5 Xq25-q27.1 U U U 
FXTAS Xq27.3 FMR1 FMRP CGG repeat 
XLSA/A Xq13.1-q13.3 ABC7 ABC7 MM 
FXTAS, Fragile X tremor/ataxia syndrome; MM, missense mutations; SCAX, X-
linked spinocerebellar ataxia; U, unknown; XLSA/A, X-linked sideroblastic 
anemia and ataxia 
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1.3 Nervous System Development 
1.3.1 Neuronal migration and brain development 
There are several distinct structures, like cerebellum, neocortex and 
thalamus, in the brain, which constitutes the central nervous system along with the 
spinal cord. These specific brain regions are assembled through connections 
between morphologically and functionally different neurons. Migration of similar 
neurons into discrete layers and their positioning in these layers during embryonic 
development is a key step in construction of unique neuronal structures.  
1.3.1.1 Formation of the cerebral cortices 
During embryogenesis, six-layered structure of the mammalian cortical 
plate is established through the serial migration of neurons from their proliferative 
regions to a final position within the cortex. This corticogenesis process is 
comprised of three stages (Figure 1.5; Gleeson & Walsh, 2000). The first step of 
the neocortical development is formation of the preplate or primordial plexiform 
layer. Preplate is established above the ventricular zone and below the pial surface 
around embryonic-day (E) 10-12 in mice and weeks 8-9 in humans. Ventricular 
zone contains proliferative cells which give rise to cortical neurons. Second step is 
construction of the cortical layers. This step begins with migration of first group 
of cortical neurons to divide the preplate into a deeper sub-plate and a superficial 
marginal zone, forming cortical plate between these two layers (Marin-Padilla, 
1998). During cortical plate stage which takes place in E 10-17 in mice and weeks 
10-18 in humans, cortical neurons exit ventricular zone, penetrate through the 
sub-plate and form sequential cortical layers. This lamination step occurs in an 
inside-out fashion. Newly-generated neurons pass the sub-plate and older cortical 
plate neurons, and settle below Cajal-Retzius cells of the marginal zone. So, early-
born cells of cortical plate remain in deeper layers and younger cells populate 
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more superficial layers (Angevine & Sidman, 1961). Degeneration of the sub-
plate and lamination of the cortical plate into six-layered neocortex is the last step 
of corticogenesis (Gleeson & Walsh, 2000). Cells migrate radially and 
tangentially during development of these neuronal layers (O’Rourke et al., 1992). 
Cortical neurons most often migrate radially along glial cells spanning cerebral 
wall to reach their final layers (Hatten, 1999). Meanwhile, a fraction of cells turn 
within the intermediate zone and migrate orthogonal to the radial fibers 
(O’Rourke et al., 1992).  
 
Figure 1.5 Development of the cerebral cortex. Neurons are deposited into 
cortical plate in an “inside-out” fashion (indicated by the progressive lighter 
shades of green in more superficial cortical plate neurons). Note radial alignment 
of the cortical neurons and the relatively cell-free marginal zone. CP, cortical 
plate; IZ, intermediate zone; MZ, marginal zone; PP, preplate; SP, subplate; VZ, 
ventricular zone; WM, white matter (Gleeson & Walsh, 2000) 
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1.3.1.2 Laminating the cerebellum 
Cerebellum development is also carried through distinct steps. There are 
two different germinative zones where the cerebellar neurons are generated. 
Ventricular zone (also known as the ventricular germinative matrix) gives rise to 
precursor cells of the deep cerebellar nuclei and the Purkinje cells of the cerebellar 
cortex. Neurons of deep nuclei are the first generated cells at about E 10-12 in 
mice (Goldowitz & Hamre, 1998) and week 8 in human embryogenesis (Wang & 
Zoghbi, 2001). Afterwards, precursors of the Purkinje cells are produced between 
E 11-13 in mice (Goldowitz & Hamre, 1998) and in week 9 in humans (Hatten, 
1999; Wang & Zoghbi, 2001). These precursor cells evolve to mature Purkinje 
cells. Maturation process continues until postnatal period. Projection of the 
Purkinje cells to the deep nuclei cells and refinement of input they receive from 
the inferior olivary complex also take place during this maturation. Purkinje cell 
precursors start to migrate towards the surface of cerebellum through the wall of 
cerebellar anlage. In the meantime precursors of the cerebellar granule neurons 
arise from the rhombic lip. Starting from week 11 in humans, the rhombic cells 
sweep across the cerebellar anlage, migrate over surface of the cerebellum and 
establish the external granular layer on the periphery of roof (Wang & Zoghbi, 
2001). Beneath the external granular layer, the Purkinje cells establish the 
Purkinje cell plate and wait for inward migration of the granule cells (Miyata et 
al., 1996, Hatten, 1999). External granular layer above the Purkinje cell plate is 
the second germinative region of the cerebellum and gives rise to the granule 
cells. These cells migrate deeper into the cortex along the radially oriented 
Bergmann glial cells through the field of differentiating Purkinje cells (Wang & 
Zoghbi, 2001). Granule cells are arrested at their final destination deeper to the 
Purkinje cells. Three layers are formed at the end of these orchestrated migrations; 
an outer molecular layer of the granule cell axons and Purkinje cell dendrites, a 
layer of the Purkinje cells and an inner layer of the granule cells (Figure 1.6). 
During the course, Purkinje cell plate overlying the germinative zone functions as 
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a scaffold for proper lamination of the cerebellar cortex (Hatten, 1999). Inward 
migration of the granule cells continues after birth and the external granular layer 
disappears within the first year of life in humans (Wang & Zoghbi, 2001). The 
cerebellar nuclei, which are likely comprised of cells moved through nuclear 
transitory zone, take their position beneath the Purkinje cell plate. Remarkably, 
the Purkinje cells are also important in regulating cell proliferation in the external 
granular layer. Sonic hedhehog, a mitogenic factor, is produced and released by 
the Purkinje cells and act on precursors of the granule neurons to control 
proliferation (Wechsler-Reya & Scott, 1999). 
 
 
Figure 1.6 Neuronal migrations during development of the cerebellum. At 
embryonic period, while Purkinje cell precursors (filled circles) are migrating 
through the wall of the cerebellar anlage, precursors of the granule cells (unfilled 
circles) sweep across the roof. Afterwards, in the perinatal period, inward 
migration of the granule cells takes place. Connections between laminated 
neurons are established during adulthood. EGL, external granular layer; IGL, 
internal granular layer; PC, Purkinje cells (Hatten, 1999)  
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1.3.2 Mouse models with neurodevelopmental defects  
Reeler and trembler mice are the classic examples of mouse models with 
congenital defects in the nervous system. These mice arose spontaneously, and 
were described more than 50 years ago (Falconer, 1951). They have been widely 
used to investigate role of neuronal migration in brain development, and to dissect 
molecular pathways regulating the choreographed migrations of neurons.  
 
1.3.2.1 Reeler mouse 
Reeler mouse was recognized with its “reeling” gait (Falconer, 1951). 
Incoordination of motor skills and ataxic condition of reeler mouse was due to its 
disrupted cortical assembly. The principal defect is neuronal malpositioning 
resulting from abnormal migration (Rakic & Caviness, 1995; D’Arcangelo et al., 
1995). Inside-out cell positioning during neurogenesis fails, and layers in the 
cerebral cortex, cerebellum, hippocampus and other laminated brain regions 
develop abnormally (Rakic & Caviness 1995; Rice & Curran, 1999). 
Neurons of reeler mice arise from their birthplace (ventricular zone, 
subventricular zone and rhombic lip) without any problem. Also cells start their 
migration on their normal program. However, they cannot establish normal 
architectural structures because they cannot find their proper location at the end of 
migration and fail to align into appropriate cell layers (Caviness, 1982; Rice & 
Curran, 1999). Yet, the rest of their differentiation program is unaffected. Neurons 
can differentiate to their destined classes, normal dendritic and axonal branching 
can be achieved, cells can establish successful connections with their targets, and 
gliogenesis and myelination are not directly affected. On the other hand since 
neurons do not stay at their normal location, the dendritic trees and axonal 
pathways are often formed abnormally. The cerebral cortex, the cerebellum, and 
the hippocampus are the most affected organs of reeler mice. Additionally, 
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abnormal development is observed in several other structures involving the spinal 
cord, brain stem, thalamus, midbrain, olivary complex, olfactory bulb, cochlear 
nuclei, facial nerve nucleus, retina, and tectum (Goffinet et al., 1984; Goffinet, 
1984; Frost et al., 1986; Rakic & Caviness, 1995; Yip et al., 1998; Rice & Curran, 
1999; Rice et al., 2001; Tissir & Goffinet, 2003).  
Abnormal development of the reeler cerebrum can be obviously seen from 
beginning of cortical plate formation at E 16. In the reeler cortex, all major 
neuron classes are generated on time in the ventricular zone and neuronal cohorts 
follow their normal migration schedule (Rice & Curran, 2001). Preplate of reeler 
mouse develops as in wild type mouse. Afterwards, however, the inside to outside 
neurogenesis in the cortical plate stage does not take place (Figure 1.7). Preplate 
cannot be divided into the marginal zone and the subplate due to failure in 
invasion of the preplate by the first cohort of migrating cortical neurons (Hoffarth 
et al., 1995; Ogawa et al., 1995; Sheppard & Pearlman, 1997; Rice & Curran, 
1999). Subsequent waves of cortical neurons can start to migrate along radial glial 
cells in the intermediate zone. But, they cannot bypass their predecessors, 
possibly because they do not penetrate the subplate or because they do not 
dissociate from radial cells properly (Pinto-Lord et al., 1982; Gleeson & Walsh, 
2000). Instead, they populate the region beneath the subplate leading to an 
inversely laminated cortex (Ogawa et al., 1995). At the end of serial migrations in 
a wild type mouse cortex, the marginal zone remains relatively cell-free except for 
Cajal-Retzius and several other neurons. The six-layered cortical plate contains 
tightly packed cells which are aligned radially and the subplate assumes the 
position beneath the cortical plate (Rice & Curran 1999; 2001). On the other hand, 
in the reeler mouse the cortical plate is inverted and its radial alignment is lost 
(Hunter-Schaedle, 1997). Although neurons seem morphologically normal, their 
axons run obliquely in the cerebral wall and their dendrites follow tortuous paths 
(Goffinet, 1979). The Cajal-Retzius cells and subplate cells remain superficial to 
this disorganized cortical plate in a cell-dense region known as the superplate 
(Figure 1.8) (Derer, 1985; Rice & Curran 1999; 2001). 
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Figure 1.7 Malpositioning of neurons in the reeler neocortex. Development of the 
reeler cerebral cortex is characterized with inability of neurons in penetrating 
through the subplate. Instead, cortical cells remain underneath the preplate and 
late generated cells do not migrate past their predecessors (indicated by 
progressive lighter shades of green in deeper cortical plate neurons). Superficial 
layer of the cortical plate is invaded by several neurons forming superplate 
structure. 6’-2’ numbers represent inverted layers of the cortical plate. Note 
neuronal projections developing at random directions. (Gleeson & Walsh, 2000)  
 
 
 
 
23 
 
 
Figure 1.8 Histological appearance of the normal and reeler telencephalon. 
Disorganized cortical plate at embryonic day 14.5 is populated with cells in an 
oblique direction. (Tissir & Goffinet, 2003) 
 
Most obvious phenotypic feature of reeler mouse is impaired gait 
coordination. This is probably due to severe developmental defect in its 
cerebellum. Number of the Purkinje cells in the reeler cerebellum is decreased 
when compared to the wild type. Radially migrating Purkinje cells stop 
prematurely on their migration path. They cannot establish the Purkinje cell plate 
and instead, reside in ectopic clusters deep in the cerebellum (Figure 1.9) 
(Goldowitz et al., 1997; Gallagher et al., 1998, Rice & Curran, 2001).  Since 
Purkinje cells cannot migrate close enough to the granule cells, granule cells do 
not receive proliferation signals from the Purkinje cells and suffer a secondary 
degeneration. Moreover, the Purkinje cells cannot function as a structural scaffold 
for construction of other regions. Disruption of foliation of the cerebellar 
structures leads to functional deficits in the cerebellum (Rice & Curran 1999; 
Tissir & Goffinet, 2003). 
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Figure 1.9 Schematic and histological appearance of the normal, reeler and 
scrambler cerebellum. A) Cells in the external granular layer (egl) and in the 
nuclear transitory zone (ntz) are reelin secreting cells (black circles) at early 
phases of development. Purkinje cell precursors (pp) express reelin receptors and 
Dab1, and migrate towards reelin secreting cells. B-C) Several days later, 
Purkinje cell plate (pcp) is established underneath the egl as can be seen in the 
micrographs (arrowheads show pcp and arrows indicate egl). In the reeler and 
scrambler cerebellum, Purkinje cells are unable to form the Purkinje cell plate. 
(Rice & Curran, 2001)  
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Development of the reeler hippocampus is also characterized by abnormal 
migration and malpositioning of neurons. Hippocampus remains poorly 
laminated; pyramidal cell layer cannot be established and granule cells reside in a 
disorganized dentate gyrus (Sweet et al., 1996; Tissir & Goffinet, 2003). 
1.3.2.2 Scrambler and yotari mice  
More than 10 years ago two new mutant mice with neurodevelopmental 
defects were discovered. The one arose spontaneously was described at the 
Jackson Laboratory (Ben Harbor, ME) and named as scrambler (Sweet et al., 
1996). Yotari that appeared during generation of knock-out mice is the second 
mutant mouse exhibiting a reeler-like phenotype (Sheldon et al., 1997; 
Yoneshima et al., 1997). 
Scrambler and yotari mice were phenotypically indistinguishable from 
reeler mice. They exhibit ataxia at 2 weeks after birth: trembling, walking with a 
wide gait, dragging hind limbs and flipping onto backs are certain signs (Howell 
et al., 1997). Impaired gait of these mice is because of defects in their cerebellum 
which develop smaller than normal and without foliation. Purkinje cells aggregate 
into a disorganized group at ectopic positions and their dendrites run at random 
directions. They fail to form a distinct layer. Granule cell population is smaller 
than normal and inward migration can be achieved by only few of them. Most of 
the granule cells reside in a superficial position to the Purkinje cells (Figure 1.9) 
(Howell et al., 1997; Goldowitz et al., 1997).  
Like in reeler mice, neurons arise and start their migration on time in 
scrambler. However, they fail to form the inside-out pattern during neurogenesis 
of laminated structures (Gonzalez et al., 1997). Abnormal migration and 
malpositioning of neurons affect a wide range region involving the cerebral cortex 
and the hippocampus. The cortical plate is inversely laminated and the marginal 
zone is invaded by neurons. Vestiges of the normal structures are present in the 
scrambler hippocampus. Nevertheless, the large pyramidal neurons are dispersed 
(Howell et al., 1997).  
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1.3.2.3 Identification of reelin and Dab1 Genes 
The reeler phenotype was found to be caused by deletion in reelin gene. 
Identification of reelin gene was achieved through a transgene insertion into the 
reeler locus (D’Arcangelo et al., 1995). Shortly after this discovery, it was found 
that disruption of the mouse disabled1 (Dab1) gene causes the scrambler and 
yotari phenotypes (Howell et al., 1997; Sheldon et al., 1997; Ware et al., 1997). 
In the meantime, mutations in Cdk5 (cyclin dependent kinase 5) gene or its 
neuronal specific activator p35 were linked to similar neurodevelopmental 
disorders in mice (Ohshima et al., 1996; Chae et al., 1997).  
 
1.3.2.4 VLDLR and ApoER2 knockout mice 
Disrupted VLDLR and ApoER2 genes, two members of the LDL receptor 
family, cause a phenotype characterized by similar behavioral and 
neuroanatomical defects observed in the reeler mouse (Trommsdorff et al., 1999). 
ApoER2 and VLDLR knock-out mice are smaller than normal and are 
ataxic at 2 weeks age. Cerebellum is smaller than normal and lacks foliation. 
Purkinje cells remain in ectopic clusters deep in the cerebellum. Pyramidal cells 
of the hippocampus are dispersed into multiple layers. Granule cells do not 
establish histotypical layers of dentate gyrus. Although corticogenesis begins 
normally, neurons migrate abnormally during construction of the cerebral wall. 
Observation of similar defects in reelin or Dab1 knock-out mice led to the 
conclusion that these proteins function on the same signaling pathway 
(Trommsdorff et al., 1999). 
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On the other hand if only VLDLR or only ApoER2 gene is targeted, mouse 
has less severe defects than double knock-out mouse. For instance, the marginal 
zone can be observed as a distinct layer in the cerebral cortex of ApoER2
-/-
 or 
VLDLR
-/-
 mice although the inner layer of the cortex is still disorganized. In 
contrast, similar to reeler and scrambler mice, in ApoER2
-/-
;VLDLR
-/-
 mice there 
is no visible marginal zone since it is invaded by ectopically positioned neurons 
(Sweet et al., 1996; Goldowitz et al., 1997; Gonzalez et al., 1997; Howell et al., 
1997; Sheldon et al., 1997; Ware et al., 1997; Trommsdorff et al., 1999).  
When neuroanatomical deficits of ApoER2
-/-
, VLDLR
-/-
 and             
ApoER2
-/-
;VLDLR
-/-
 mice are compared, it would be observed that the cerebellum 
is the most affected organ in VLDLR
-/-
 mice and the cerebral cortex is the most 
affected structure in ApoER2
-/-
 mice. Only mice lacking both receptors exhibit an 
identical phenotype of reeler or scrambler mice which have extensive disruptions 
in both the cerebellum and cerebral cortex (Trommsdorff et al., 1999).  
In the cerebellum of VLDLR
-/-
 mouse, the Purkinje cells do not 
appropriately receive Reelin signal sent from the granule cells in the external 
granular layer. So the Purkinje cells do not complete their migration and fail to 
form the Purkinje cell plate. Nevertheless, Purkinje cells of ApoER2
-/-
 mouse can 
establish a distinct layer in the cerebellum although they are smaller than normal 
cells and their projections are randomly organized (Trommsdorff et al., 1999). 
During development of the cerebral cortex of ApoER2 deficient mouse, 
cortical layers are formed inversely since most of the neurons fail to reach their 
normal positions and are horizontally aligned. Yet, in VLDLR
-/-
 mouse, cortical 
neurons can migrate in a radial alignment and find their normal layer. But VLDLR 
deficiency prevents them to distribute properly in their determined layer 
(Trommsdorff et al., 1999). 
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Moreover, in a recent study it was shown that ApoER2 and VLDLR are 
involved in different steps of neuronal migration during cortical development; 
whereas proper migration of late generated neurons depends on functional 
ApoER2 protein, VLDLR is required to prevent migrating neurons from invading 
the marginal zone (Hack et al., 2007). 
All these findings demonstrate that ApoER2 and VLDLR have similar 
functions and one receptor can partially compensate for the loss of other receptor. 
Yet, since they can have divergent functions at some points, both of them are 
important and required for proper development of the laminated brain regions 
(Rice & Curran, 1999; 2001).  
 
1.3.3 Reelin signaling pathway 
After identification and characterization of reelin, several studies were 
performed to constitute a linear signaling pathway guiding neurons on their way 
during development of nervous system. 
These studies revealed that Reelin is a large glycoprotein (D’Arcangelo et 
al., 1997) secreted by Cajal-Retzius cells in the marginal zone of the cerebral 
cortex (D’Arcangelo et al., 1995; Hirotsune et al., 1995; Ogawa et al., 1995), and 
by the external granular layer and deep cerebellar nuclei neurons in the 
cerebellum (D’Arcangelo et al., 1995, Miyata et al., 1996). Reelin binds to 
VLDLR and ApoER2 and is internalized subsequently (D’Arcangelo et al., 1999, 
Hiesberger et al., 1999). Binding of Reelin to these lipoprotein receptors induces a 
tyrosine signaling cascade that phosphorylates Dab1 (Howell et al., 1999). Dab1 
is an adaptor protein and interacts with NPxY motifs in the cytoplasmic tails of 
VLDLR and ApoER2 (Howell et al., 1999; Rice & Curran, 2001). Hence, VLDL 
receptor and ApoER2 are necessary to transmit Reelin signal to intracellular 
molecules for proper positioning of cells in brain development. 
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Cadherin-related neuronal receptors (Senzaki et al., 1999) and α3β1 
integrin (Dulabon et al., 2000) are other transmembrane proteins that Reelin can 
bind.  
Dab1 is phosphorylated by Src family tyrosine kinases (Arnaud et al., 
2003; Bock & Herz, 2003). Activation of Dab1 promotes two different signaling 
pathways. One of them is a kinase cascade modulating activity of tau protein, a 
microtubule stabilizing protein (Hiesberger et al., 1999). The other pathway 
regulates actin cytoskeleton through Crkl/C3G/Rap1 cascade (Ballif et al., 2004). 
Lis1, which is an important regulator of cell positioning during cortical lamination 
is another intracellular partner of Reelin pathway and binds to phosphorylated 
Dab1 upon Reelin stimulation (Assadi et al., 2003). Pafah1b complex formed by 
Lis1 and two other subunits was also found to be interacting with VLDL receptor 
and was recently integrated into Reelin pathway (Zhang et al., 2007). 
Reelin may dictate different and comparable signals on migrating neurons. 
It can be a stop signal arresting migration of neurons (Dulabon et al., 2000), a 
chemoattractant for migrating neurons (Gilmore & Herrup, 2000), or it can be 
necessary for the timely detachment of migrating neurons (Hack et al., 2002; 
Sanada et al., 2004).   
 
 
1.4. Aim and Strategy 
The aim of this study is to identify the gene(s) that are associated with 
quadrupedal locomotion (Unertan syndrome) in humans. Linkage genome scan 
using high-density microarray platform, homozygosity mapping and candidate 
gene analysis strategies were employed to achieve this goal.  
 
30 
 
PART II: MATERIALS AND METHODS 
 
 
 
 
 
2.1 Recruitment of Families 
Four consanguineous families, family A, family B, family C and family D, 
all from Turkey and exhibiting Unertan syndrome, were studied. Healthy and 
affected members of these families were referred to Bilkent University, Faculty of 
Science, Molecular Biology and Genetics Department (Ankara, Turkey) by 
collaborating physicians at Cukurova University, Faculty of Science (Adana, 
Turkey). Patients and other unaffected individuals were enrolled after obtaining 
informed consent according to the protocols approved by the Ethics Committees 
of Baskent and Cukurova Universities with the decision numbers KA07/47, 
02.04.2007 and 21/3, 08.11.2005, respectively. 
 
2.2 DNA and RNA Samples 
2.2.1 Sample collection 
Peripheral blood was obtained from available patient and healthy members 
of the families. Samples were collected in tubes containing EDTA. They were 
divided into 1 ml aliquots in 1.5 ml eppendorf tubes. The samples have been 
stored at -80°C. 
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2.2.2 DNA isolation from blood samples 
200 µl blood was used for each DNA isolation reaction. To prepare DNA 
from blood, Nucleospin™ Blood kit (Macherey-Nagel Inc., PA, USA) (#740 
951.250) was used according to the manufacturer’s instructions. Concentration of 
the DNA was determined by using NanoDrop™ ND-1000 UV-Vis 
Spectrophotometer.  
 
2.2.3 Amplification of purified genomic DNA 
2.5 µl purified genomic DNA was amplified with REPLI-g™ Midi kit 
(Qiagen Inc.) (#150043) according to the manufacturer’s guidelines. 
Concentration of amplified DNA was checked by using NanoDrop™ ND-1000 
UV-Vis Spectrophotometer.  
 
2.2.4 RNA isolation from blood samples 
For extraction of RNA from blood, QlAamp™ RNA Blood Mini kit 
(Qiagen Inc.) (#52304) was used with 1.5 ml blood. After performing isolations 
according to the manufacturer’s instructions, NanoDrop™ ND-1000 UV-Vis 
Spectrophotometer was used to quantify concentration of RNA.  
 
2.2.5 cDNA synthesis 
cDNA was prepared from 11 µl RNA with RevertAid™ First Strand 
cDNA Synthesis kit (MBI Fermentas, Amh, NY, USA) (#K1622) according to the 
guidelines of the manufacturer.  
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2.3 Genetic Mapping 
 Determining mode of inheritance is the first and one of the critical steps in 
genetic modeling of human disorders. Hereditary human disorders have 
chromosomal, Mendelian (single gene disorders) or complex inheritance patterns. 
Conditions of the complex inheritance include reduced penetrance, imprinting 
effect, mitochondrial inheritance, dynamic mutations, epistasis, and gene-
environment interaction. On the other hand, diseases obeying Mendelian rules can 
be inherited over autosomes or sex chromosomes. Autosomal characters can be 
dominant or recessive, and sex linked characters are basically divided into          
X-linked dominant, X-linked recessive and Y-linked (Strachan & Read, 2004). 
 Pedigree analysis of the families diagnosed with Unertan syndrome 
revealed that the disorder has not been observed over generations. Instead, disease 
arises in one generation implying vertical transmission, and affected children are 
resulting from consanguineous marriages. Because of these reasons the mode of 
inheritance was decided as autosomal recessive. 
 Second step of genetic modeling studies is to determine how to approach 
mapping the disease. One approach is candidate gene analysis which was not used 
initially in our studies since there was no obvious candidate. So, the other method, 
whole genome genotyping, was performed.  
  
2.3.1 Genome-wide linkage analysis  
Whole-genome SNP genotyping was performed with the commercial 
release of the GeneChip® 250K (NspI digest) or GeneChip® 10K Affymetrix 
arrays as described (Matsuzaki et al., 2004). Guidelines in GeneChip® mapping 
assay manuals provided by Affymetrix were followed to carry out experiments 
(Figure 2.1). 
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Figure 2.1 Workflow of GeneChip® mapping 10K (left) and 500K (NspI digest; right) assays (Affymetrix 10K and 500K manuals).
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 The third step of genetic mapping is to decide statistical analysis strategy. 
According to presence or absence of an inheritance mode, parametric or non-
parametric statistics method is used to analyze genome wide data obtained from 
the SNP chips. Parametric analysis is used in linkage studies, and need a pre-
determined inheritance mode and large families exhibiting the phenotype. There is 
no need to know inheritance mode while using non-parametric statistic method 
and because of this it is used in association studies in disorders demonstrating 
complex inheritance. Since our pedigrees perfectly fit autosomal recessive 
inheritance with full penetrance, we used parametric, linkage, approach to analyze 
the data generated from SNP chips. 
 To analyze SNP chip data computer based statistical analysis programs are 
used. These programs include LINKAGE, GENE HUNTER, ALLEGRO and 
MERLIN programs. MERLIN program was used in our analysis since it allows 
the user to handle very large numbers of markers rapidly and efficiently   
(Abecasis et al., 2002). It also facilitates fast multipoint analysis which contains 
number of markers in an interval, i.e relevant markers in 1 cM interval. Hence, 
multipoint linkage analysis was done with the parametric component of the 
MERLIN Package v1.01 (Abecasis et al., 2002; Abecasis & Wigginton, 2005).  
Next step is preparing the input files which describe the pedigree, analytic 
parameters, map information and marker list included in the analysis. There are 
four files used by the MERLIN program. These are pedigree, data, map, and 
model files. Pedigree file, i.e UTS.ped, describes relationships between 
individuals and their disease status (Table 2.1). Data file, i.e UTS.dat, contains 
the list of markers and describe the affection status, i.e rare disorders with a model 
estimation (Table 2.2). Map file, i.e UTS.map, contains the order and genetic 
positions of the SNP markers (Table 2.3). Disease model is described in the model 
file, i.e UTS.model, in which we specified the disorder as very rare disease   
(Table 2.4).  
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Table 2.1 Part of pedigree file for family A. Family A was divided into two parts 
for convenience as shown with numbers 1 and 2 in the family column. In sex 
column, numbers 1 and 2 indicates male and female respectively. Data for SNP 
markers of each individual are given in genotypes column. In status column, 
numbers 1 and 2 indicates unaffected and affected individuals respectively. F, 
family; FID, father identification number; MID, mother identification number; 
PID, personal identification number; S, sex 
F PID FID MID S Genotypes Status 
1 1 0 0 2 1/1 2/2 1/1 1/1 0/0 1/1 1 
1 2 0 0 1 1/1 0/0 1/1 1/1 1/1 1/1 1 
1    3 2 1 2 1/1 1/2 1/1 1/1 0/0 1/1 1 
1 4 2 1 1 1/1 2/2 1/1 1/1 1/1 1/1 2 
1 5 2 1 1 1/1 0/0 1/1 1/1 0/0 1/1 1 
1 6 2 1 2 1/1 2/2 1/1 1/1 1/2 1/1 2 
1 7 2 1 2 1/1 2/2 1/1 1/1 1/1 1/1 1 
2 1 0 0 2 1/1 2/2 1/1 1/1 1/1 1/1 1 
2 2 0 0 1 1/1 2/2 2/2 1/1 1/2 1/2 1 
2 3 2 1 1 1/1 2/2 1/1 1/1 1/2 1/2 2 
2 4 2 1 2 1/1 2/2 0/0 1/1 1/2 1/2 1 
2 5 2 1 1 1/1 2/2 1/2 1/1 1/1 1/2 1 
2 6 2 1 2 1/1 2/2 1/2 1/1 1/1 1/2 1 
2 7 2 1 1 1/1 2/2 0/0 1/1 1/2 1/1 2 
2 8 2 1 2 1/1 2/2 1/1 1/1 1/1 1/2 1 
2 9 0 0 1 1/1 2/2 2/2 1/1 1/1 1/1 1 
2 10 2 1 2 1/1 2/2 2/2 1/1 1/2 1/2 1 
2 11 9 10 2 1/1 1/2 2/2 1/1 1/2 1/1 2 
2 13 9 10 2 1/1 2/2 2/2 1/1 1/1 0/0 1 
2 14 9 10 1 1/1 2/2 2/2 1/1 1/1 1/2 1 
2 15 9 10 1 1/1 2/2 2/2 1/1 1/2 0/0 1 
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Table 2.2 Part of data file for family A. Second column are the list of the 
markers. Very rare disease describes the disease and refers to the model file where 
penetrance values of the disease are given. A, affection status; M, marker 
M SNP_A-1513154 
M SNP_A-1511366 
M SNP_A-1509154 
M SNP_A-1514257 
M SNP_A-1518033 
M SNP_A-1516287 
M SNP_A-1516246 
M SNP_A-1514307 
M SNP_A-1509247 
M SNP_A-1515558 
M SNP_A-1511470 
M SNP_A-1507812 
M SNP_A-1509562 
M SNP_A-1518487 
M SNP_A-1509919 
M SNP_A-1512266 
M SNP_A-1510062 
M SNP_A-1512471 
M SNP_A-1511505 
M SNP_A-1510562 
M SNP_A-1519343 
M SNP_A-1515796 
M SNP_A-1516100 
M SNP_A-1515465 
M SNP_A-1515289 
M SNP_A-1519085 
M SNP_A-1509293 
M SNP_A-1518948 
M SNP_A-1508116 
. . 
. . 
. . 
. . 
A VERY_RARE_DISEASE 
E END-OF-DATA 
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Table 2.3 Part of map file showing a sample of SNP markers from     
chromosome 1, for family A. SNP names and their genetic positions are given in 
the second and third columns respectively. CHR, chromosome number 
       
CHR       MARKER 
           
LOCATION 
1 SNP_A-1509443 3.859.407 
1 SNP_A-1518557 5.848.183 
1 SNP_A-1517286 8.655.963 
1 SNP_A-1516024 8.853.158 
1 SNP_A-1514538 9.387.403 
1 SNP_A-1516403 9.510.903 
1 SNP_A-1518687 12.351.566 
1 SNP_A-1509959 12.353.228 
1 SNP_A-1515791 13.890.000 
1 SNP_A-1513560 13.891.000 
1 SNP_A-1512212 13.892.000 
1 SNP_A-1519671 14.865.946 
1 SNP_A-1515942 15.275.197 
1 SNP_A-1512107 20.442.669 
1 SNP_A-1514390 21.496.830 
1 SNP_A-1518041 24.577.258 
1 SNP_A-1508673 28.395.543 
1 SNP_A-1519660 28.663.799 
1 SNP_A-1511922 28.677.756 
1 SNP_A-1510413 28.678.445 
1 SNP_A-1509189 29.025.883 
1 SNP_A-1518353 29.446.071 
1 SNP_A-1509509 29.753.222 
1 SNP_A-1516958 30.998.694 
1 SNP_A-1515835 31.231.667 
1 SNP_A-1516239 31.907.546 
. . . 
. . . 
. . . 
. . . 
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Table 2.4 Part of model file for family A. We specified the disorder as very rare 
disease, and determined penetrance as 0.0001, 0.0001 and 0.9999 for individuals 
carrying, respectively, 0, 1 and 2 copies of the disease allele 
VERY_RARE_DISEASE 0.0001 0.0001, 0.0001, 0.9999 Rare_recessive 
    
 
After description of the input files, the analysis was carried out along a 
grid of locations equally spaced at 1 cM, which allows multipoint analysis in 1 
cM interval. And the graphic was plotted as a pdf output which is given at results 
part. The syntax used in the analysis is:  
Prompt> merlin –d UTS.dat –p UTS.ped –m UTS.map -- model 
UTS.model -- grid1 -- markerNames -- pdf  
 
2.3.2 Homozygosity mapping and haplotype analysis  
Haplotypes were constructed and homozygosity regions were determined 
through visual inspection of the genotype data. Haplotype analysis was performed 
on chromosomal regions with positive lod scores. Lod score is logarithm of the 
odds ratio which is ratio of probability of linkage of a trait and a marker over 
probability of no-linkage between the disease and the marker. Lod scores are 
calculated for several estimates of recombination frequency values and a lod score 
greater than 3.0 is considered as evidence for linkage. In addition to MERLIN 
analysis, MLINK component of the LINKAGE program (FASTLINK, version 3) 
was used for pairwise linkage analysis (Lathrop & Lalouel, 1984;         
Cottingham et al., 1993; Schaffer et al., 1994). 
Polymorphic markers from the critical intervals of chromosomes 9p24 
(D9S1779 [0.4 Mb] and D9S1871 [3.7 Mb]) and 17p13 (D17S1298 [3.51 Mb]) 
were used to test for homozygosity to the respective chromosomal loci. 
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2.4 Candidate Gene Analysis 
 
2.4.1 Polymerase Chain Reaction (PCR) 
2.4.1.1 Primers 
Primers covering exons of VLDLR gene in NC_000009 sequence were 
designed by using Primer3 (http://frodo.wi.mit.edu/) and BLAST 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) websites (Table 2.5). Primers were 
purchased from Iontek Inc. (Istanbul, Turkey). 
 
2.4.1.2 PCR conditions 
4 µl DNA (100-150 ng) was used as a template with 2.5 µl PCR buffer 
(10X), 1.5 µL MgCl2 (25 mM), 0.3 µl dNTPs (10mM), 1 µl (10pmol/µl) from 
each primer and 0.2 µl Taq DNA Polymerase (5u/µl) (MBI Fermentas, Amh, NY, 
USA) (#EP0402). Volume of the sample was adjusted to 25 µl with ddH2O.  
Reactions were performed in the Techne™ TC-512 and Techgene thermal 
cyclers. Reaction conditions were 5 min initial denaturation at 94°C, followed by 
35 cycles of 94°C for 30 sec, 58°C – 62°C (A.T.) for 30 sec and 72°C for 30 sec 
or 40 sec and 5 min final extension at 72°C. A.T. is the annealing temperature at 
which the primer pair binds to its specific target sequence. 
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Table 2.5 Primers that were used for sequencing of VLDLR gene. 
Primer 
Name 
Forward Primer (5’ to 3’) Reverse Primer (5’ to 3’) 
Amplified 
Region 
Product  
Size (bp) 
Primer Pair 1 ACTCACGCACGCTCACACT TCCGAAAGGAGGAAGAAGGT Exon 1 495 
Primer Pair 2 GGAGGAGACTGTGCAAGTTGT GTGGGCAAACGGAGACCTAC Exon 1 366 
Primer Pair 3 TCCCCATCCATGGGTATTAG TGATAACCCCACGTCAAACA Exon 2 365 
Primer Pair 4 TGAGCCCTCATGTGAAGCTA TGTTGGACCAGGGAGAACAT Exon 3 388 
Primer Pair 5 GCAGCAGCTTTGCATTGAT AGAAACACCAAGCGATGGTC Exon 4 328 
Primer Pair 6 TGAACGGACCAATCTTGATG GTCGCATACCCAGCTGATG Exon 5 243 
Primer Pair 7 CCCATGAGTTCCAGTGCAG CTTTCAGGGGCTCATCACTC Exons 5-6-7 659 
Primer Pair 8 CCGATGAAGTCAACTGCAAA CCTACCTGGGCTTTTAAGTCA Exon 7 396 
Primer Pair 9 GGTAACTTGCCGAGGAGTTAGA CAGAATTAGTCTTGCTGCTCCT Exon 8 398 
Primer Pair 10 GCAGGTGATGGGAAAGGATA CAACAGCCATACCAGTCCAA Exon 9 231 
Primer Pair 11 TGGGAGGAGGTGGTTTAGAA CGATGCTAGATGGGGCTAGA Exon 10 355 
Primer Pair 12 TGAGCTGTGGTGTTAACTGGA TCCTGACCTACACAGATACCATTC Exon 11 400 
Primer Pair 13 TGCCTTGAGTTTTCTGCTCA AGTTGAGTGGGTGGTCGAGA Exon 12 258 
Primer Pair 14 GCTTCGCAAGGTTTATGGTG AAGCCATGTTCAGCTGCTCT Exon 13 389 
Primer Pair 15 TGTCCCAGTTCAGCATTCAG GGGTACAGGAGGGCAAAAGT Exon 14 389 
Primer Pair 16 GGCAAGGACTCAGGTCTTCA CCCGGCATACAATAGCAGAT Exon 15 378 
Primer Pair 17 ACAGCTAGCCATGCTGGAAC CCAGGAACAACTCTGGCTTA Exon 16 391 
Primer Pair 18 GCCAGAGTTGTTCCTGGTGT ACAGCATAAAGGCCCATGAA Exon 17 325 
Primer Pair 19 GGCCCATGTGTATTCCAACT CACCCAGGTCTCCTTTCTGA Exon 18 392 
Primer Pair 20 CAACTCAAAAGCAAGGTCCA GGTAACCACATCCAAAGCTGA Exon 19 338 
Primer Pair 21 CTCTCGGCTGGAAGAACATC CCTATTGCCATTGTCCCAAC Exon 19 360 
Primer Pair 22 CTTCAGCTTTGGATGTGGTT CCAGCCCAATTACAGGCTTA Exon 19 540 
Primer Pair 23 AGGACTGGTAACTTGTCGTGCGGAG GCAGCCAGAGCGCCCAGAGCG Repeats in 5’ UTR 106 
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2.4.1.3 Agarose gel electrophoresis 
1X TAE electrophoresis buffer was used to dissolve agarose (Basica LE, 
EU) with final percentage of 1.5 % and ethidium bromide with final concentration 
of 30 ng/µl.  
PCR product was mixed with 1/5 volume of 6X loading dye solution 
before loading onto agarose gel. 1X TAE was used as running buffer for gel with 
different voltage and time parameters depending on size of the fragment. pUC 
Mix Marker 8 (0.1 µg/µl) (MBI Fermentas, Amh, NY, USA) (#SM0303) was 
used as DNA marker. GelDoc imaging system (Bio-Rad, CA, USA) with 
MultiAnalyst software version 1.1 (Bio-Rad, CA, USA) was used to visualize gel 
and take photographs. 
 
 
 
 
 
 
 
 
Figure 2.2 Sizes of the fragments of pUC Mix 
Marker 8 and appearance on agarose gel 
electrophoresis. 
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2.4.2 Mutation search 
2.4.2.1 Sequencing reactions 
PCR products with 20 µl volume and varying concentrations were used for 
sequencing reactions. They were purified and sequenced by Iontek Corp. 
(Istanbul, Turkey) by using forward and reverse primers for sense and antisense 
strand sequencing.  
2.4.2.2 Data analysis 
Sequencing data were analyzed using Chromas Lite 2.01 (Technelysium 
Pty Ltd) software.  
ClustalW website (http://www.ebi.ac.uk/Tools/clustalw2/index.html) was 
used for sequence alignment. 
 
2.4.3 Restriction digestion assay 
Families and other control individuals were genotyped with           
(i) F-5'-CCCATGAGTTCCAGTGCAG-3' and                                                                                       
R-5'-CTTTCAGGGGCTCATCACTC-3' primer pair, and            
(ii) F-5'-GCCAGAGTTGTTCCTGGTGT-3' and                  
R-5'-ACAGCATAAAGGCCCATGAA -3' primer pair             
to screen, respectively, c769C->T and c2339delT mutations. 
PCR conditions were 94
o
C for 5 min as initial denaturation followed by 35 
cycles of 94
o
C for 30 sec, 62
o
C (primer pair (i)) / 58
o
C (primer pair (ii)) for 30 sec 
and 72
o
C for 40 sec and 72
o
C for 5 min as final extension. 
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Restriction enzyme digestion was carried out from 5 µl PCR product. PCR           
products were obtained by using primer pair 7 or primer pair 18 and were digested     
with 0.10 µl HphI (10 u/µl) (MBI Fermentas, Amh, NY, USA) or 0.20 µl MboI 
(10 u/µl) (MBI Fermentas, Amh, NY, USA) enzymes respectively, 2 µl restriction 
buffer and 12.80 µl ddH2O. Restriction site for HphI enzyme is (5'-GGTGA 
(N)8-3') and for MboI enzyme is (5'-GATC -3'). Restriction digestion reactions 
were incubated at 37°C water-bath for 3-4 hours. Digestion products were run on 
1.5 % agarose gel after mixed with 4 µl 6X loading dye solution. pUC Mix 
Marker 8 (0.1 µg/µl) was used as DNA marker. GelDoc imaging system with 
MultiAnalyst software was used to visualize gel. 
 
2.4.4 Quantitative real-time reverse transcriptase PCR (Q-PCR) 
 The sequences of the primers targeting VLDLR cDNA were:  
 F-5'-CGAGACTGTCAAAGTACTGCAACTA-3' and    
 R-5'-CACTAAGAGCAAGAGAGGAAGAATG-3'.  
GAPDH (glyceraldehyde-3-phosphate dehydrogenase), and KDR (kinase 
insert domain receptor) were used as reference genes and primers for their cDNAs 
were:                    
(i) KDR (F-5'-CTCAGCAGGATGGCAAAGAC-3' and                    
R-5'-CAGATACTGACTGATTCCTGCTGT-3'),             
(ii) GAPDH (F-5'-GGCTGAGAACGGGAAGCTTGTCAT-3' and              
R-5'-CAGCCTTCTCCATGGTGGTGAAGA-3'). 
Reactions were performed with cDNA-specific primers according to the 
SYBR Green I protocol in iCycler (Bio-Rad, CA, USA). 1 µl of cDNA was used 
in 25 µl PCR reaction mixture containing 12.5 µl SYBR Green mix (Bio-Rad, 
CA, USA), 0.5 µl of each primer (10 pmol/µl) and 10.5 µl ddH2O. To cover top 
of the mixture, 25 µl mineral oil was added to each tube. 
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All reactions were performed in duplicate with the following cycling 
protocol: 10 min heat start at 94
o
C and 50 cycles of denaturation at 94
o
C for 30 s, 
annealing at 60
o
C for 30 s and extension at 72
o
C for 30 s. Melting curve analysis 
was performed following amplification step by raising temperature from 55°C to 
94°C with 0.5°C increments at each 15 seconds. Relative expression ratios were 
calculated from duplicate samples using comparative Ct method (Pfaffi, 2004) and 
normalized according to the housekeeping gene GAPDH and the endothelial 
marker KDR.  
Real-time PCR products were run on 1.5% agarose gel after mixed with 5 
µl 6X loading dye solution. pUC Mix Marker 8 (0.1 µg/µl) was used as DNA 
marker. GelDoc imaging system with MultiAnalyst software was used to visualize 
gel. 
 
 
2.5 Solutions and Buffers 
- 1X TAE (Tris-acetic acid-EDTA): 40mM Tris acetate, 2 Nm EDTA, pH 8.0 
- Ethidium bromide: 10 mg/ml in water for stock solution  
- Agarose gel loading buffer (6X): 15% ficoll, 0.05% bromophenol, 0.05% xylene 
cyanol   
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PART III: RESULTS 
 
 
 
 
 
3.1 Clinical Assessment 
Habitual and efficient quadrupedal locomotion is the cardinal and 
distinctive feature of the affected individuals (Figure 3.1). Quadruped individuals 
began to crawl on hands and knees or feet and they could never walk upright. 
They are well balanced without any ataxic movements while walking on their 
hands and feet. They can stand up for a short period of time, but they do not gain 
a fully erect position. While standing up, their bodies with their legs remain in a 
flexed position. They use both diagonal and lateral sequence gaits while walking 
quadrupedally. Their hands make contact with the ground at the ulnar palm with 
the weight taken on the wrists and lower ulnar area of the palm. Fingers make 
little or no contact with the ground preventing wearing of fingers. They can even 
hold objects with their fingers that are raised off the ground while walking (Tan, 
2005; 2006a; Humphrey et al., 2005, Turkmen et al., 2006).  
One of the affected individuals in family A (VII:1 in figure 1.1) and one in 
family C (IV:1 in figure 1.3) can use bipedal gait although these patients are 
severely ataxic. Also, aunt of the proband in family D (I:4 in figure 1.4) can walk 
bipedally, but she prefers to walk in a quadrupedal fashion despite her advanced 
age (Tan, 2006b; Ozcelik et al., 2008a).  
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Figure 3.1 Quadrupedal palmigrate walking of Unertan syndrome patients. 
Locomotion on all four extremities is exemplified by affected brothers VI:20 and 
VI:18 and cousin VI:25 in family A (Upper), and the proband II:2 in family D 
(Lower). The ulnar palm area is heavily callused like in the case of VI:20 since 
hands make contact with the ground at that area while walking. Strabismus was 
observed in all affected individuals. (Ozcelik et al., 2008a) 
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Another important characteristic of the phenotype is dysarthria. Affected 
individuals can use little or no language and have limited vocabulary. Their 
mother and father can rather easily communicate with them, but not the other 
people. Mini Mental State Examination Test (standardized for the uneducated 
Turkish people) was used to determine cognitive abilities and consciousness of 
the affected individuals. Patients do not know time, place, and date implying that 
they are mentally retarded and have no conscious experience. Nevertheless, they 
exhibit no autistic features; they all have good interpersonal skills, are friendly 
and curious to visitors. They can understand and follow very simple questions and 
commands (Tan, 2006a; Ozcelik et al., 2008a). 
Upon neurological assessment, mild thoracal scoliosis is found in patients 
and this prevents them from holding their heads upright. Affected individuals do 
not exhibit any extrapyramidal signs and have no muscle weakness, sensory loss 
or deformities. All patients had hyperactive lower leg and vivid upper extremity 
reflexes. Moreover their cranial nerves are intact. Yet, their muscle tonus and 
tendon reflexes are mildly decreased and they had bilateral dysmetria and 
dysdiadochokinesis (Tan, 2006a). Additional clinical information on affected 
individuals in families A and D is provided in Table 3.1 (Ozcelik et al., 2008a). 
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Table 3.1* Physical and neurological findings of the patients in families A and D (Ozcelik et al., 2008a). 
                                                                                                                             Family A                                                                 Family D                               
Traits VI:1 VI:18 VI:20 VI:25 VI:27 VII:1 II:2 I:4 I:5 
Gender Male Male Male Male Female Female Male Female Male 
Age 35 46 37 17 12 17 38 65 63 
Height (cm) 158 152 145 150 135 142 148 150 147 
Speech Dysarthric Dysarthric Dysarthric Dysarthric Dysarthric Dysarthric Dysarthric Dysarthric Dysarthric 
Mental 
retardation 
Profound Profound Profound Profound Profound Severe Profound Profound Profound 
Gait Quadrupedal Quadrupedal Quadrupedal Quadrupedal Quadrupedal Ataxic Quadrupedal Quadrupedal/ataxic Quadrupedal 
Truncal ataxia Severe Severe Severe Severe Severe Moderate Severe Moderate to severe Severe 
Romberg Absent Absent Absent Absent Absent Absent Absent Absent Absent 
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Epilepsy Absent Absent Absent Absent Absent Present  Absent Absent Absent 
Arm-reflexes Hyper Vivid Normal Normal Normal Vivid Vivid Vivid Vivid 
Leg-reflexes Hyper Vivid Hyper Hyper Hyper Hyper Hyper Hyper Hyper 
Hoffman (R) Absent Present Present Absent Absent Absent Not done Not done Not done 
Hoffman (L) Absent Present  Present  Absent Absent Absent Not done Not done Not done 
Trommer (R) Absent Absent Present  Absent Absent Present  Not done Not done Not done 
Trommer (L) Absent Absent Present  Absent Absent Present  Not done Not done Not done 
Babinsky (R) Present  Absent Absent Absent Present  Present  Not done Not done Not done 
Babinsky (L) (+) Absent Absent Absent Present  Absent Not done Not done Not done 
Clonus (R) Absent Absent Absent Present  Absent Absent Not done Not done Not done 
Clonus (L) Absent Absent Absent Present  Absent Absent Not done Not done Not done 
Spasticity Absent Absent Absent Absent Absent Absent Absent Absent Absent 
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Force (arms) Normal Normal Normal Normal Normal Normal Normal Normal Normal 
Force (legs) Normal Normal Normal Normal Normal Normal Normal Normal Normal 
Int.tremor(R) Absent Absent Absent Present  Absent Present  Absent Absent Absent 
Int.tremor(L) Absent Absent Absent Present  Absent Absent Absent Absent Absent 
Dysmetria(R) Mild Mild Absent Mild No response Absent Not done Not done Not done 
Dysmetria(L) Mild Mild Absent Mild No response Mild Not done Not done Not done 
Head (cm) 53 55 52.5 53 51 54 Not done Not done Not done 
Menstruation n.a. n.a. n.a. n.a Premenstrual (+) n.a Post-menopausal n.a. 
Cal. Nys. (R) > 2 min > 2 min > 2 min > 2 min > 2 min > 2 min Not done Not done Not done 
Cal. Nys. (L) > 2 min > 2 min > 2 min > 2 min > 2 min > 2 min Not done Not done Not done 
Mental status as measured by Developmental Quotient (DQ) estimated by clinical history was judged as severe retardation (DQ 20 to 34) and 
profound retardation (DQ < 20). Dysmetria as measured by finger chase test judged as mild when under/overshooting target < 5 cm.            
R, right; L, left; Cal. Nys., caloric nystagmus; n.a., not applicable. 
*Detailed clinical information can be obtained from: family A: Tan et al., 2008a; family D: Tan, 2008b
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Neuroradiological examination revealed that the cerebellum and the 
cerebellar vermis of the quadrupedal individuals are hypoplastic. Inferior portion 
is completely lost and midline is fissured in the vermis (Figure 3.2). These 
findings can be accompanied by small brainstem and the pons, simplification of 
the cortical gyri, and hypoplasia of corpus callosum in some patients (Tan, 2006a; 
Ozcelik et al., 2008a). Similar signs except for hypoplasia of the corpus callosum 
are also observed in the MRI scans of two siblings walking bipedally in family B 
(Turkmen et al., 2006).  
 
 
Figure 3.2 Neuroradiological images of affected individuals. Hypoplasia of the 
vermis which lacks inferior part, and the cerebellar hemispheres is seen in coronal 
and midsagittal MRI sections of VI:20 in family A. Cortical gyral simplification, 
and small brainstem and the pons are other findings (left and center). II:2 in 
family D displays similar signs (right). (Ozcelik et al., 2008a) 
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3.2 Chromosomal Loci Associated With Quadrupedal Locomotion 
In family A, Affymetrix 250K GeneChip® was used for genome wide 
linkage analysis which revealed two regions on chromosomes 9p and 15q with 
positive lod scores (Appendix A). MERLIN or other linkage programs test for co-
segregation between the disease allele and the DNA markers selected from the 
region of interest. It does not detect homozygosity information in the region. 
Therefore, for recessive disorders all regions providing positive lod scores should 
also be tested for homozygosity by inspecting haplotypes. With this aim, 
informative markers covering the regions with positive location scores were 
selected. Further haplotype analysis and homozygosity mapping with these 
markers confirmed linkage of the disease loci to a 1.032-Mb region between 
rs7847373 and rs10968723 markers on chromosome 9p24 (Figure 3.3) and 
exclude the locus in chromosome 15q (Figure 3.4).  
Disease loci in family B was linked to chromosome 17p13, confirming a 
previous study (Turkmen et al., 2006). In family C, no homozygosity was 
identified for the critical regions on chromosomes 9p24 (Figure 3.5) and 17p13 
(Figure 3.6) and multipoint linkage analysis yielded highly negative lod scores, 
excluding both loci; gene mapping in this family is ongoing. 
Figure 3.3 Homozygosity mapping of cerebellar hypoplasia and 
quadrupedal locomotion to chromosome 9p24. Affected individuals were 
indicated with filled symbols in the pedigree of family A. Regions associated with 
the disease allele of Unertan syndrome was represented with black bars. 
Boundaries for the disease locus were defined between markers rs7847373 and 
rs10968723 by recombination events in individuals VI:16 (obligate carrier) and 
VII:4 (normal sibling). Physical positions and pairwise lod scores for each marker 
are shown on the upper left. Zmax represents the maximum lod score obtained at 
Ɵ=0.00 cM (Ozcelik et al., 2008a). 
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Figure 3.4 Haplotype analysis of family A using SNP markers from 15q residing between the 55- and 65-Mb region. The order 
of SNP markers based on physical positions is shown on the upper left. Although whole genome SNP genotyping gave positive 
lod scores for that region, homozygosity was not detected among affected individuals in the haplotype analysis of the entire 
pedigree. Absence of consensus between the branches in the haplotype and negative scores in multipoint linkage analysis 
(bottom right) confirmed exclusion of the 15q region (Ozcelik et al., 2008a). 
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Figure 3.5 Exclusion of chromosome 9p24 in family C. SNP markers in the critical 
interval were tested in haplotype and multipoint linkage analysis (Ozcelik et al., 
2008a). 
56 
 
 
Figure 3.6 Haplotype and exclusion analyses of family C using polymorphic 
markers from 17p13 critical region. Graphical presentation of the multipoint 
linkage analysis using the information obtained from 10K SNP array is shown on 
the bottom left. Haplotype was constructed with the polymorphic markers selected 
from the same critical region (Ozcelik et al., 2008a). 
 
 
57 
 
 
In family D, whole genome SNP genotyping was not done. Instead, 
polymorphic markers from the critical intervals of chromosomes 9p24 and 17p13 
were tested. The pedigree showed homozygosity in chromosome 9p24. 
 
3.2.1 Genetic heterogeneity; Unertan syndrome type I 
The families exhibiting Unertan syndrome are living in isolated villages 
apart from each other and there is no documented ancestral relationship between 
the families. However, Unertan syndrome is a very rare disease, only six families 
reported until now. Because of this we expected a single locus shared by affected 
individuals in all families. But, mapping studies resulted in three different 
chromosomal localizations in our families. These are chromosome 9p24 in family 
A and family D, and chromosome 17p13 in family B (Turkmen et al., 2006; 
Ozcelik et al., 2008a). Disease trait of family C could not be linked to either 
17p13 or 9p24 regions (Ozcelik et al., 2008a). These results revealed genetic 
heterogeneity in Unertan syndrome.  
Hence, the condition in families A and D is proposed as “Unertan 
syndrome type 1” (Ozcelik et al., 2008a).  
 
3.3 Candidate Gene Analysis in 9p24 
3.3.1 VLDLR as a candidate gene 
The critical region on chromosome 9p24 includes SMARCA2 (SWI/SNF-
related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, 
member 2), VLDLR (very low density lipoprotein receptor), KCNV2 (potassium 
channel, voltage-gated, subfamily V, member 2), and KIAA0020 (minor 
histocompatibility antigen HA-8) genes.  
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Among these genes VLDLR was selected as a prime positional candidate. 
The rationale behind this selection was that a gene involved in nervous system 
development, neuronal migration, and cerebellar maturation could be involved in 
the pathogenesis of quadrupedal gait. Additionally, it was previously shown that a 
genomic deletion including VLDLR causes cerebellar hypoplasia with cerebral 
gyral simplification (Boycott et al., 2005) 
 
3.3.2 VLDLR sequencing in families A and D 
  37-year-old male of family A (VI:20) was studied as index patient. He 
ambulates in a quadrupedal manner. His speech is dysarthric and cognitive 
abilities are severely reduced with no conscious experience.  Hypoplasia of the 
cerebellum and the cerebellar vermis with complete loss of inferior vermis, 
moderately simplified cerebral cortical gyri, and small brainstem and the pons are 
his MRI scan findings. 
Index patient of Family D (II:2) was a 38-year-old male. Profound mental 
retardation, dysarthria, and truncal ataxia accompany his quadrupedal locomotion. 
His cerebellum and vermis are hypoplastic and can be observed along with 
moderate simplification of cortical gyri in MRI brain scans. 
Sequencing of VLDLR gene exons from genomic DNA of these affected 
individuals revealed a homozygous c769C->T mutation in family A and a 
homozygous c2339delT mutation in family D (Figure 3.7; Ozcelik et al., 2008a). 
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Figure 3.7 Chromatograms presenting VLDLR c769C->T mutation in family A (A) and VLDLR c2339delT mutation in family D 
(B) (Ozcelik et al., 2008a).  
B A 
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3.3.3 Restriction endonuclease based mutation screening in families A and D  
Family A was screened for c769C->T mutation. There is no restriction site 
for HphI enzyme (5'-GGTGA (N)8-3') in the respective amplicon of DNA of a 
homozygous normal individual, and c769 C -> T mutation introduces a restriction 
site. Single band at 659 bp was observed for homozygous normal individuals, two 
bands of 463 and 196 were observed in homozygous mutant individuals as 
expected.  
Family D members were genotyped with the particular primers to screen 
c2339delT mutation. Respective amplicon of DNA of a homozygous normal 
individual contains two restriction sites for MboI enzyme (5'-GATC -3'), one of 
which would be eliminated by c2339delT mutation. The corresponding band sizes 
at the result of digestion were 217 and 106 bp bands for homozygous mutant 
individuals, and 181, 106 and 37 bp bands for homozygous normal individuals.  
VLDLR mutation segregates with the disease in the members of both 
families (Figure 3.8). All patients are homozygous mutant, and all tested parents 
are heterozygous for the wild-type allele. Carriers of the families A and D were 
identified with this assay.
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Figure 3.8 Restriction enzyme based mutation screening in family A (A) and family D (B). Fragment sizes of the DNA size marker 
(M) are 1118, 881, 692, 501, 404, 331, 242, and 190 bp in (A), and 331, 242, 190, 147, and 111 bp in (B). (Ozcelik et al., 2008a)
A 
B 
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3.3.4 VLDLR sequencing in family B and C 
Family B and family C did not share homozygosity for chromosome 9p24. 
Yet, certain human genetic traits can be caused by compound heterozygous 
mutations – presence of two different mutant alleles at the same gene.  
To exclude the possibility of compound heterozygosity, VLDLR gene 
exons were sequenced from genomic DNA of the probands of Family B (V:11) 
and Family C (III:2). Sequencing of VLDLR did not reveal any mutations in both 
patients (Appendix B; Ozcelik et al., 2008a). 
 
3.3.5 Restriction enzyme based mutation screening in control individuals 
200 individuals including 50 individuals from southeast, 50 individuals 
from west and remaining 100 individuals from different geographical locations in 
Turkey were selected to screen both mutations in normal population. HphI and 
MboI enzymes were used to screen c769C -> T and c2339delT mutations 
respectively, following genotyping of individuals with the particular primer pairs. 
Single band at 659 bp was observed for homozygous normal individuals with 
HphI digestion and three bands with 181, 106 and 37 bp sizes were observed for 
homozygous normal individuals with MboI digestion. DNA of an affected 
individual in Family A (VI:1) was used as HphI digestion control. Positive control 
was not necessary for MboI digestion since it has already restriction sites in 
homozygous normal genotype. All control individuals were homozygous normal 
for both mutations (Figure 3.9). 
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Figure 3.9 Screening of c769C->T (A) and c2339delT (B) mutations in control 
individuals. (Ozcelik et al., 2008a) 
 
3.4 Quantitative Analysis of VLDLR Expression in Affected and Unaffected 
Individuals 
Expression levels of VLDLR gene in affected individuals of families A and 
D (8 patients; 6 patients from family A and 2 patients from family D), and in 4 
control individuals were compared using Q-PCR (Figure 3.10 and 3.11).  
VLDLR gene is very lowly expressed in blood and primers specific for 
VLDLR cDNA were normalized by diluting cDNAs from 1µl to 2-3µl.  Relative 
expression levels were calculated according to the formula: 
Expression change = n
- (∆CT patient - ∆CT control) 
Where; n is the normalization number (depends on efficiency of the primers), CT 
is the threshold cycle for each sample, and ∆CT represents the difference between 
threshold cycles of VLDLR and GAPDH or VLDLR and KDR.  
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Figure 3.10 PCR amp/cycle graph for VLDLR. 
 
 
Figure 3.11 Melt curve graph for VLDLR. 
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There was no considerable difference for VLDLR expression between 
patients and controls (Figure 3.12; Ozcelik et al., 2008a).  
 
 
Figure 3.12 Quantitative analysis of VLDLR expression in patients and controls. 
Normalization number is 1.15 for VLDLR cDNA primers. When VLDLR 
expression in controls (Control) is assumed as 1, VLDLR expression in patients 
normalized to GAPDH (VLDLR-GAPDH) would be 1.12 ± 0.19, and VLDLR 
expression in patients normalized to KDR (VLDLR-KDR) would be 1.26 ± 0.26. 
(Ozcelik et al., 2008a) 
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PART IV: DISCUSSION and CONCLUSION 
 
 
 
 
 
 In the context of this research, homozygosity mapping and candidate gene 
sequencing were performed in four consanguineous families diagnosed with 
Unertan syndrome. Cerebellar hypoplasia, quadrupedal locomotion and mental 
retardation are the trademarks of this recessively inherited disorder.   
Homozygosity mapping linked Unertan syndrome to three different loci, 
demonstrating genetic heterogeneity in the disease. Genetic heterogeneity is 
frequently observed in numerous several human genetic diseases. For example 
there are more than 130 different autosomal recessive, autosomal dominant and 
X-linked loci, and countless distinct mutations leading to hereditary deafness.  
The loci linked to Unertan syndrome are chromosome 9p24 in families A 
and D, 17p13 in family B, and neither loci in family C. The minimal regions in 
9p24 and 17p13 were found to be 1.032-Mb and 7.116-Mb intervals, respectively. 
Since the 17p13 interval is large and contains at least 150 genes, our efforts first 
targeted 9p24. There are 4 genes in the 9p24 region. Of these, very low density 
lipoprotein receptor (VLDLR) appeared as a prime positional candidate because of 
its expression in the cerebellum. Sequencing of VLDLR exons from genomic 
DNA revealed two distinct mutations that lead to truncated VLDL receptors; 
c769C->T, results in a stop codon, R257X, in ligand binding type repeats, and 
c2339delT mutation causes a frameshift, I780TfsX3 and generates a stop codon in 
O-linked sugar domain (Figure 4.1; Ozcelik et al., 2008a). These mutations 
prevent the receptor to be inserted into membrane and to transmit Reelin signal to 
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intracellular partners. During brain development, these disruptions in VLDLR 
preclude formation of the neural structures that are critical for gait. Same 
phenotype caused by different mutations in the same gene implies allelic 
heterogeneity in the disorder. Allelic heterogeneity can also be observed in 
numerous human genetic disorders. Hypercholesterolemia, which was linked to 
>300 different mutations in the LDL receptor, can be given as an example for a 
disorder with allelic heterogeneity (Ozcelik et al., 2008b).  
As a consequence of genetic heterogeneity and identified genetic changes, 
the condition in families A and D is proposed as “VLDLR-associated 
Quadrupedal Locomotion” (VLDLR-QL) or Unertan Syndrome Type 1. 
Identification of VLDLR mutations in Unertan syndrome extends the 
knowledge about the role of Reelin signaling pathway in neuronal migration 
disorders and in pathogenesis of neurodevelopmental movement diseases. Reelin 
signaling pathway is involved in lamination of neurons into distinct cortical 
layers, and disruptions of certain proteins in the pathway are implicated in specific 
cortical dysgenesis disorders. Homozygous mutations have been identified in the 
human Reelin (RELN) gene producing Norman-Roberts type lissencephaly 
syndrome (OMIM 257320; Hong et al., 2000). This type of lissencephaly 
syndrome is characterized with moderately thickened cortex and pachygyria, 
abnormalities in the hippocampus, and severe cerebellar hypoplasia with absent 
folia (Ross & Walsh, 2001). Mutations in the human RELN are similar to 
naturally occurring mouse Reln alleles that lead to reeler phenotype in mice with 
ataxic gait and trembling (Hong et al., 2000; D’Arcangelo et al., 1995). Mouse 
deficient for VLDLR was also studied. Engineered mouse lacking VLDL receptor 
appear grossly normal and has a normal life span (Frykman et al., 1995). 
Nonetheless, similar to the hypoplastic cerebellum in humans with VLDLR 
mutation (Ozcelik et al., 2008), the mouse cerebellum is smaller and has less 
folium, where Purkinje cells have failed to form the Purkinje cell plate, in the 
absence of VLDL receptor (Trommsdorff et al., 1999).   
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Figure 4.1 Schematic representation of the mutations in exons (A) and functional domains (B) of VLDLR. VLDLR gene consists of 19 
exons and encodes a protein of 873 amino acids. Locations of the mutations are shown with arrows. LBTR, ligand-binding type 
repeat; EGFR, epidermal growth factor repeat I–III; YWTD, YWTD –propeller; OLSD, O-linked sugar domain; TD, transmembrane 
domain; CD, cytoplasmic domain (Ozcelik et al., 2008a; Herz & Bock, 2002; www.expasy.org/uniprot/P98155).
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4.1 Unertan Syndrome vs. Disequilibrium Syndrome 
Another disorder caused by VLDLR-associated genomic abnormalities is a 
form of disequilibrium syndrome described in the Hutterite population of North 
America (DES-H, OMIM 224050; Boycott et al. 2005). Disequilibrium syndrome 
was initially described as an autosomal recessive disorder of cerebral palsy 
associated with a variety of developmental abnormalities involving disturbed 
equilibrium, severe motor retardation, impaired cognitive skills, muscular 
hypotonia, and perceptual abnormalities (Hagberg et al., 1972; Sanner, 1973). 
Disequilibrium syndrome found in the Hutterites manifests itself with 
nonprogressive hypoplasia of the cerebellum, simplification of cerebral gyri, 
moderate-to-profound mental retardation, truncal ataxia and delayed ambulation, 
and caused by a homozygous deletion of a 199-kb region encompassing VLDLR 
gene (Boycott et al. 2005). 
 Affected individuals of Unertan syndrome and disequilibrium syndrome 
have quite similar clinical findings. Nevertheless, habitual and efficient 
quadrupedal locomotion is distinctive feature of Unertan syndrome patients 
(Table 4.1; Ozcelik et al., 2008a). Most of the disequilibrium patients cannot walk 
independently and others learn to walk very late. Those who can walk have a wide 
based, non tandem gait. Yet, they do not ambulate in a quadrupedal fashion. This 
is also the case for DES-H patients (Glass et al., 2005). On the other hand, 
individuals with Unertan syndrome ambulate in a quadrupedal manner with their 
hands and feet in both diagonal and lateral sequence gaits. Among patients in 
families A and D, independent bipedal gait can be achieved only by two affected 
individuals whom; however, prefers quadrupedal walking most of the time 
(Ozcelik et al., 2008b; Turkmen et al. 2008). 
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Table 4.1 Physical, radiological, and genetic characteristics of the Turkish families in this study and of Hutterite family DES-H (Glass et al., 
2005; Ozcelik et al., 2008a). Cvs, central vestibular system; Pvs, peripheral vestibular system.. 
 Family A Family B Family C Family D DES-H 
Chromosomal location 9p24 17p Not 9p or 17p 9p24 9p24 
Gene and mutation VLDLR (c769CT) unknown unknown VLDLR (c2339delT) 
Deletion including            
VLDLR and LOC401491 
Gait quadrupedal quadrupedal quadrupedal quadrupedal bipedal 
Speech dysarthric dysarthric dysarthric dysarthric dysarthric 
Hypotonia absent absent absent absent present 
Barany caloric nystagmus normal Cvs defect Pvs defect not done not done 
Mental retardation profound severe to profound profound profound moderate to profound 
Ambulation delayed delayed delayed delayed delayed 
Truncal ataxia severe severe severe severe severe 
Lower leg reflexes hyperactive hyperactive hyperactive hyperactive hyperactive 
Upper extremity reflexes vivid vivid vivid vivid vivid 
Tremor very rare mild present absent present 
Pes-planus present present present present present 
Seizures very rare rare rare absent observed in 40% of cases 
Strabismus present present present present present 
Inferior cerebellum hypoplasia hypoplasia mild hypoplasia hypoplasia hypoplasia 
Inferior vermis absent absent normal absent absent 
Cortical gyri mild simplification mild simplification mild simplification mild simplification mild simplification 
Corpus callosum normal reduced normal normal normal 
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A possible explanation for the gait difference between these two 
syndromes may be impairment of motor skills required for quadrupedal gait in the 
DES-H patients. This type of motor retardation can prevent them to perform 
quadrupedal locomotion and force them to walk bipedally. Such a severe 
phenotype seen in the Hutterite patients can be due to 199-kb deletion including 
the entire VLDLR gene and part of a hypothetical gene, LOC401491. Also, since 
the deleted region is a large interval, expression of neighboring genes can be 
affected due to the absence of intergenic regulatory elements (Boycott et al., 
2005).  
When genotype-phenotype correlations of Unertan syndrome and DES-H 
are compared, clinical heterogeneity should also be considered. Conclusion of 
different mutation in the same gene with different clinical phenotypes is not a rare 
situation in medical genetics. For example, certain mutations in cadherin 23 result 
in blindness and deafness, whereas other mutations in the same gene cause 
hearing loss with normal vision. Clinical heterogeneity is also applicable for 
Unertan syndrome and disequilibrium syndrome phenotypes (Ozcelik et al., 
2008b). The Hutterite families in North America, families A and D in Turkey, and 
a family diagnosed with disequilibrium syndrome in Iran, all have different 
genomic abnormalities of VLDLR gene. Whereas DES-H patients lack the entire 
VLDLR gene (Boycott et al., 2005), Iranian patients have a nonsense change in 
exon 10 of the same gene (Moheb et al., 2008). On the other hand, the mutations 
in Turkish families A and D are, respectively, a nonsense change in exon 5 and a 
single-base-pair deletion in exon 17 leading to a frameshift in VLDLR (Ozcelik et 
al., 2008a). These different abnormalities of VLDLR gene have resulted in 
different movement disorders including late bipedal ambulation (Boycott et al., 
2005), ataxic gait (Moheb et al., 2008), and quadrupedal locomotion (Ozcelik et 
al., 2008a) along with cerebellar hypoplasia in all three cases.  
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4.2 Is Quadrupedal Locomotion an Environmental Adaptation? 
 Quadrupedal locomotion of the affected individuals in Turkish families 
can be considered as an adaptation to their congenital cerebellar ataxia because of 
poor environmental conditions, including lack of access to proper medical care, 
local cultural environment, or religious beliefs of the parents. 
 Inadequate medical care would not lead to quadrupedality in the patients 
because we have already known that families A and D looked for medical 
treatments to improve gait of their affected children. In addition to 
discouragement of affected children from quadrupedal walking by their parents, 
there is a physician who participated in medical interventions in family A. On the 
other hand, mother of the index patient in family D consulted with private medical 
practices and two major academic medical centers for a definitive diagnosis and 
correction of the disorder in her son. Unfortunately, all these efforts did not 
prevent quadrupedal locomotion in the affected individuals (Ozcelik et al., 
2008a). Zimmer frames that were provided to certain affected individuals during 
studies helped them in upright walking. However, this does not eradicate genetic 
basis of quadrupedal walking since for example the correction of myopia with 
help of glasses does not mean that near-sightedness is not a genetic condition 
 Local cultural environment and religious beliefs are also highly unlikely to 
lead to quadrupedal walking of the patients. It would not be true to assume that 
walking in a quadrupedal manner was suppressed in the Hutterites, and yet it was 
tolerated and was not corrected in the Turkish families due to certain cultural and 
religious factors. This assumption has been falsified by families who did not 
tolerate quadrupedal walking, but instead searched for medical therapies. Also, 
recently described family with quadruped members in Brazil (Garcias & Roth, 
2007) demonstrates that quadrupedal gait is rather a distinct phenotype than an 
adaptation mechanism.  
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4.5 Future Prospects 
  Cerebellar hypoplasia and quadrupedal locomotion in humans was linked 
to at least three different chromosomes with our studies. Gene in one of these 
chromosomal loci, 9p24, was identified as VLDLR. It would be interesting to 
identify genes responsible for the disorder in other families. 
  After the identification of causative mutations in a disease, easy and 
affordable DNA-based diagnostic testing becomes possible. This is indeed true for 
VLDLR since both mutations can be detected by specific PCR and restriction 
endonuclease cleavage, thus giving us the opportunity to perform carrier 
identification and population screening. 
Observing development of animals with mutant VLDL receptors could 
give further details about the pathogenesis of this syndrome, and also about the 
role of VLDLR in development of nervous system required for gait in humans. 
    
  
  
 74 
PART V: REFERENCES 
 
 
 
 
 
 
Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002). Merlin--rapid 
analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 30:97-
101. 
Abecasis GR & Wigginton JE (2005). Handling marker-marker linkage 
disequilibrium: pedigree analysis with clustered markers. Am J Hum Genet. 
77:754-67. 
Angevine JB Jr & Sidman RL (1961). Autoradiographic study of cell 
migration during histogenesis of cerebral cortex in the mouse. Nature. 192:766-8. 
Arnaud L, Ballif BA, Förster E, Cooper JA (2003). Fyn tyrosine kinase is 
a critical regulator of disabled-1 during brain development. Curr Biol. 13:9-17.  
Assadi AH, Zhang G, Beffert U, McNeil RS, Renfro AL, Niu S, 
Quattrocchi CC, Antalffy BA, Sheldon M, Armstrong DD, Wynshaw-Boris A, 
Herz J, D'Arcangelo G, Clark GD (2003). Interaction of reelin signaling and Lis1 
in brain development. Nat Genet. 35:270-6. 
Ballif BA, Arnaud L, Arthur WT, Guris D, Imamoto A, Cooper JA (2004). 
Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. 
Curr Biol. 14:606-10. Erratum in: Curr Biol. 2004. 14:742. 
 75 
Banfi S & Zoghbi HY (1994). Molecular genetics of hereditary ataxias. 
Baillieres Clin Neurol. 3:281-95. 
Bock HH & Herz J (2003). Reelin activates SRC family tyrosine kinases 
in neurons. Curr Biol. 13:18-26.  
Boycott KM, Flavelle S, Bureau A, Glass HC, Fujiwara TM, Wirrell E, 
Davey K, Chudley AE, Scott JN, McLeod DR, Parboosingh JS (2005). 
Homozygous deletion of the very low density lipoprotein receptor gene causes 
autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am J 
Hum Genet. 77:477–483. 
Caviness VS Jr (1982). Neocortical histogenesis in normal and reeler 
mice: a developmental study based upon [3H]thymidine autoradiography. Brain 
Res. 256:293-302. 
Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH (1997). Mice 
lacking p35, a neuronal specific activator of Cdk5, display cortical lamination 
defects, seizures, and adult lethality. Neuron. 18:29-42. 
Cottingham RW Jr, Idury RM, Schäffer AA (1993). Faster sequential 
genetic linkage computations. Am J Hum Genet. 53:252-63. 
D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T 
(1995). A protein related to extracellular matrix proteins deleted in the mouse 
mutant reeler. Nature. 374:719-23.  
D'Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Curran T 
(1997). Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal 
antibody. J Neurosci. 17:23-31. 
D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran 
T (1999). Reelin is a ligand for lipoprotein receptors. Neuron. 24:471-9. 
 
 76 
Derer P (1985). Comparative localization of Cajal-Retzius cells in the 
neocortex of normal and reeler mutant mice fetuses. Neurosci Lett. 54:1-6. 
Di Donato S (1998). The complex clinical and genetic classification of 
inherited ataxias. I. Dominant ataxias. Ital J Neurol Sci. 19:335-43. 
Di Donato S, Gellera C, Mariotti C (2001). The complex clinical and 
genetic classification of inherited ataxias. II. Autosomal recessive ataxias. Neurol 
Sci. 22:219-28. 
Dueñas AM, Goold R, Giunti P (2006). Molecular pathogenesis of 
spinocerebellar ataxias. Brain. 129:1357-70. 
Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, Walsh CA, 
Kreidberg JA, Anton ES (2000). Reelin binds alpha3beta1 integrin and inhibits 
neuronal migration. Neuron. 27:33-44. 
Espinós-Armero C, González-Cabo P, Palau-Martínez F (2005). 
Autosomal recessive cerebellar ataxias. Their classification, genetic features and 
pathophysiology. Rev Neurol. 41:409-22. 
Falconer DS (1951). Two new mutants trembler and reeler, with 
neurological actions in the house mouse. J. Genet. 50:192-201 
Fogel BL & Perlman S (2007). Clinical features and molecular genetics of 
autosomal recessive cerebellar ataxias. Lancet Neurol. 6:245-57. 
Frost DO, Edwards MA, Sachs GM, Caviness VS Jr (1986). Retinotectal 
projection in reeler mutant mice: relationships among axon trajectories, 
arborization patterns and cytoarchitecture. Brain Res. 393:109-20. 
 
 
 
 77 
Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J (1995). 
Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a 
disruption in the gene encoding very low density lipoprotein receptor. Proc Natl 
Acad Sci U S A. 92:8453-7. 
Gallagher E, Howell BW, Soriano P, Cooper JA, Hawkes R (1998). 
Cerebellar abnormalities in the disabled (mdab1-1) mouse. J Comp Neurol. 
402:238-51. 
Garcias Gde L & Roth Mda G (2007). A Brazilian family with 
quadrupedal gait, severe mental retardation, coarse facial characteristics, and 
hirsutism. Int J Neurosci. 117:927-33. 
Gatchel JR & Zoghbi HY (2005).Diseases of unstable repeat expansion: 
mechanisms and common principles. Nat Rev Genet. 6:743-55. 
Gilmore EC & Herrup K (2000). Cortical development: receiving reelin. 
Curr Biol. 10:R162-6. 
Glass HC, Boycott KM, Adams C, Barlow K, Scott JN, Chudley AE, 
Fujiwara TM, Morgan K, Wirrell E, McLeod DR (2005). Autosomal recessive 
cerebellar hypoplasia in the Hutterite population. Dev Med Child Neurol. 47:691–
695. 
Gleeson JG & Walsh CA (2000). Neuronal migration disorders: from 
genetic diseases to developmental mechanisms. Trends Neurosci. 23:352-9.  
Goffinet AM (1979). An early development defect in the cerebral cortex 
of the reeler mouse. A morphological study leading to a hypothesis concerning the 
action of the mutant gene. Anat Embryol (Berl). 157:205-16. 
 
 
 78 
Goffinet AM (1984). Abnormal development of the facial nerve nucleus in 
reeler mutant mice. J Anat. 138:207-15. 
Goffinet AM, So KF, Yamamoto M, Edwards M, Caviness VS Jr (1984). 
Architectonic and hodological organization of the cerebellum in reeler mutant 
mice. Brain Res. 318:263-76.  
Goldowitz D, Cushing RC, Laywell E, D'Arcangelo G, Sheldon M, Sweet 
HO, Davisson M, Steindler D, Curran T (1997). Cerebellar disorganization 
characteristic of reeler in scrambler mutant mice despite presence of reelin. J 
Neurosci. 17:8767-77. 
Goldowitz D & Hamre K (1998). The cells and molecules that make a 
cerebellum. Trends Neurosci. 21:375-82.  
González JL, Russo CJ, Goldowitz D, Sweet HO, Davisson MT, Walsh 
CA (1997). Birthdate and cell marker analysis of scrambler: a novel mutation 
affecting cortical development with a reeler-like phenotype. J Neurosci.   
17:9204-11. 
Hack I, Bancila M, Loulier K, Carroll P, Cremer H (2002). Reelin is a 
detachment signal in tangential chain-migration during postnatal neurogenesis. 
Nat Neurosci. 5:939-45. 
Hack I, Hellwig S, Junghans D, Brunne B, Bock HH, Zhao S, Frotscher M 
(2007). Divergent roles of ApoER2 and Vldlr in the migration of cortical neurons. 
Development. 134:3883-91. 
Hagberg B, Sanner G, Steen M (1972). The dysequilibrium syndrome in 
cerebral palsy. Clinical aspects and treatment. Acta Paediatr Scand Suppl.    
226:1-63. 
 
 
 79 
Harding AE (1993) in Inherited Ataxias, ed Harding AE & Deufel T     
(New York: Raven) Vol 61, pp 1–14. 
Hatten ME (1999). Central nervous system neuronal migration. Annu Rev 
Neurosci. 22:511-39. 
Herz J & Bock HH (2002). Lipoprotein receptors in the nervous system. 
Annu Rev Biochem. 71:405-34.  
Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, 
Cooper JA, Herz J (1999). Direct binding of Reelin to VLDL receptor and ApoE 
receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau 
phosphorylation. Neuron. 24:481-9. 
Hirotsune S, Takahara T, Sasaki N, Hirose K, Yoshiki A, Ohashi T, 
Kusakabe M, Murakami Y, Muramatsu M, Watanabe S, Nakao K, Katsuki 
M, Hayashizaki Y (1995) The reeler gene encodes a protein with an EGF-like 
motif expressed by pioneer neurons. Nat Genet. 10:77-83.  
Hoffarth RM, Johnston JG, Krushel LA, van der Kooy D (1995). The 
mouse mutation reeler causes increased adhesion within a subpopulation of early 
postmitotic cortical neurons. J Neurosci. 15:4838-50. 
Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO, 
Martin ND, Walsh CA (2000). Autosomal recessive lissencephaly with cerebellar 
hypoplasia is associated with human RELN mutations. Nat Genet. 26:93-6. 
Erratum in: Nat Genet. 2001. 27:225. 
Howell BW, Hawkes R, Soriano P, Cooper JA (1997). Neuronal position 
in the developing brain is regulated by mouse disabled-1. Nature. 389:733-7.  
 
 
 80 
Howell BW, Herrick TM, Cooper JA (1999). Reelin-induced tyrosine 
phosphorylation of disabled 1 during neuronal positioning. Genes Dev.13:643-8. 
Erratum in: Genes Dev. 13:1642.  
Humphrey N, Skoyles JR, Keynes R (2005). Human hand-walkers: Five 
siblings who never stood up. Discussion paper, Centre for Philos of Nat and Soc 
Sci London. 
Hunter-Schaedle KE (1997). Radial glial cell development and 
transformation are disturbed in reeler forebrain. J Neurobiol. 33:459-72. 
Lathrop GM & Lalouel JM (1984). Easy calculations of lod scores and 
genetic risks on small computers. Am J Hum Genet. 36:460-5. 
Marin-Padilla M (1998). Cajal-Retzius cells and the development of the 
neocortex. Trends Neurosci. 21:64-71. 
Mariotti C & Di Donato S (2001). Cerebellar/spinocerebellar syndromes. 
Neurol Sci. 22 Suppl 2:S88-92.  
Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E, Law J, Berntsen T, 
Chadha M, Hui H, Yang G, Kennedy GC, Webster TA, Cawley S, Walsh PS, 
Jones KW, Fodor SP, Mei R (2004). Genotyping over 100,000 SNPs on a pair of 
oligonucleotide arrays. Nat Methods. 1:109-11.  
Miyata T, Nakajima K, Aruga J, Takahashi S, Ikenaka K, Mikoshiba K, 
Ogawa M (1996). Distribution of a reeler gene-related antigen in the developing 
cerebellum: an immunohistochemical study with an allogeneic antibody CR-50 on 
normal and reeler mice. J Comp Neurol. 372:215-28. 
 
 
 
 81 
Moheb LA, Tzschach A, Garshasbi M, Kahrizi K, Darvish H, Heshmati Y, 
Kordi A, Najmabadi H, Ropers HH, Kuss AW (2008). Identification of a 
nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in 
an Iranian family with dysequilibrium syndrome. Eur J Hum Genet. 16:270-3 
Ogawa M, Miyata T, Nakajima K, Yagyu K, Seike M, Ikenaka K, 
Yamamoto H, Mikoshiba K (1995). The reeler gene-associated antigen on Cajal-
Retzius neurons is a crucial molecule for laminar organization of cortical neurons. 
Neuron. 14:899-912. 
Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, 
Brady RO, Martin LJ, Kulkarni AB (1996). Targeted disruption of the cyclin-
dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology 
and perinatal death. Proc Natl Acad Sci U S A. 93:11173-8. 
O'Rourke NA, Dailey ME, Smith SJ, McConnell SK (1992). Diverse 
migratory pathways in the developing cerebral cortex. Science. 258:299-302.  
Orr HT & Zoghbi HY (2007). Trinucleotide repeat disorders. Annu Rev 
Neurosci. 30:575-621. 
Ozcelik T, Akarsu N, Uz E, Caglayan S, Gulsuner S, Onat OE, Tan M, 
Tan U (2008a). Mutations in the very low-density lipoprotein receptor VLDLR 
cause cerebellar hypoplasia and quadrupedal locomotion in humans. Proc Natl 
Acad Sci U S A. 105:4232-6.  
Ozcelik T, Akarsu N, Uz E, Caglayan S, Gulsuner S, Onat OE, Tan M, 
Tan U (2008b). Reply to Herz et al. and Humphrey et al.: Genetic heterogeneity 
of cerebellar hypoplasia with quadrupedal locomotion. Proc Natl Acad Sci U S A. 
105:E32-3. 
 
 
 82 
Palau F & Espinós C (2006). Autosomal recessive cerebellar ataxias. 
Orphanet J Rare Dis. 1:47. 
Perlman SL (2004). Symptomatic and disease-modifying therapy for the 
progressive ataxias. Neurologist. 10:275-89. 
Pfaffi MW (2004) in A-Z of Quantitative PCR, ed Bustin S (International 
University Line, La Jolla, CA), pp 89–120. 
Pinto-Lord MC, Evrard P, Caviness VS Jr (1982). Obstructed neuronal 
migration along radial glial fibers in the neocortex of the reeler mouse: a Golgi-
EM analysis. Brain Res. 256:379-93. 
Rakic P & Caviness VS Jr (1995). Cortical development: view from 
neurological mutants two decades later. Neuron. 14:1101-4. 
Rice DS & Curran T (1999). Mutant mice with scrambled brains: 
understanding the signaling pathways that control cell positioning in the CNS. 
Genes Dev. 13:2758-73. 
Rice DS & Curran T (2001). Role of the reelin signaling pathway in 
central nervous system development. Annu Rev Neurosci. 24: 1005-039. 
Rice DS, Nusinowitz S, Azimi AM, Martínez A, Soriano E, Curran T 
(2001). The reelin pathway modulates the structure and function of retinal 
synaptic circuitry. Neuron. 31:929-41. 
Ross ME & Walsh CA (2001). Human brain malformations and their 
lessons for neuronal migration. Annu Rev Neurosci. 24:1041-70. 
Sanada K, Gupta A, Tsai LH (2004). Disabled-1-regulated adhesion of 
migrating neurons to radial glial fiber contributes to neuronal positioning during 
early corticogenesis. Neuron. 42:197-211. 
 
 83 
Sanner G (1973). The dysequilibrium syndrome. A genetic study. 
Neuropadiatrie. 4:403-13. 
Schäffer AA, Gupta SK, Shriram K, Cottingham RW Jr (1994). Avoiding 
recomputation in linkage analysis. Hum Hered. 44:225-37. 
Schöls L, Bauer P, Schmidt T, Schulte T, Riess O (2004). Autosomal 
dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet 
Neurol. 3:291-304. 
Senzaki K, Ogawa M, Yagi T (1999). Proteins of the CNR family are 
multiple receptors for Reelin. Cell. 99:635-47. 
Sheldon M, Rice DS, D'Arcangelo G, Yoneshima H, Nakajima K, 
Mikoshiba K, Howell BW, Cooper JA, Goldowitz D, Curran T (1997). Scrambler 
and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. 
Nature. 389:730-3.  
Sheppard AM & Pearlman AL (1997). Abnormal reorganization of 
preplate neurons and their associated extracellular matrix: an early manifestation 
of altered neocortical development in the reeler mutant mouse. J Comp Neurol. 
378:173-9. 
Strachan T & Read AP (2004). Human Molecular Genetics – 3rd ed., 
(Garland Science, New York, NY), pp 101-109. 
Sweet HO, Bronson RT, Johnson KR, Cook SA, Davisson MT (1996). 
Scrambler, a new neurological mutation of the mouse with abnormalities of 
neuronal migration. Mamm Genome. 7:798-802. 
Tan U (2005). Unertan syndrome: A new theory on the evolution of 
human mind. Neuroquantology. 4: 250-255. 
 
 84 
Tan U (2006a). A new syndrome with quadrupedal gait, primitive speech, 
and severe mental retardation as a live model for human evolution. Int J Neurosci. 
116:361-9. 
Tan U (2006b). Evidence for “Unertan syndrome” and the evolution of the 
human mind. Int J Neurosci. 116:763-74. 
Tan U, Karaca S, Tan M, Yilmaz B, Bagci NK, Ozkur A, Pence S (2008a). 
Unertan syndrome: a case series demonstrating human devolution. Int J Neurosci. 
118:1-25. 
Tan U (2008b). Unertan syndrome: review and report of four new cases. 
Int J Neurosci. 118:211-25. 
Tissir F & Goffinet AM (2003). Reelin and brain development. Nat Rev 
Neurosci. 4:496-505. 
Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, 
Nimpf J, Hammer RE, Richardson JA, Herz J (1999). Reeler/Disabled-like 
disruption of neuronal migration in knockout mice lacking the VLDL receptor and 
ApoE receptor 2. Cell. 97:689-701. 
Turkmen S, Demirhan O, Hoffmann K, Diers A, Zimmer C, Sperling K, 
Mundlos S (2006). Cerebellar hypoplasia and quadrupedal locomotion in humans 
as a recessive trait mapping to chromosome 17p. J Med Genet. 43:461-4. 
Turkmen S, Hoffmann K, Demirhan O, Aruoba D, Humphrey N, Mundlos 
S (2008). Cerebellar hypoplasia, with quadrupedal locomotion, caused by 
mutations in the very low-density lipoprotein receptor gene. Eur J Hum Genet. 
2008. [Epub ahead of print] 
 
 
 85 
Wang VY & Zoghbi HY (2001). Genetic regulation of cerebellar 
development. Nat Rev Neurosci. 2:484-91. 
Ware ML, Fox JW, González JL, Davis NM, Lambert de Rouvroit C, 
Russo CJ, Chua SC Jr, Goffinet AM, Walsh CA (1997). Aberrant splicing of a 
mouse disabled homolog, mdab1, in the scrambler mouse. Neuron. 19:239-49. 
Wechsler-Reya RJ & Scott MP (1999). Control of neuronal precursor 
proliferation in the cerebellum by Sonic Hedgehog. Neuron. 22:103-14.  
Yip JW, Yip YP, Nakajima K, Capriotti C (2000).Reelin controls position 
of autonomic neurons in the spinal cord. Proc Natl Acad Sci U S A. 97:8612-6. 
Yoneshima H, Nagata E, Matsumoto M, Yamada M, Nakajima K, Miyata 
T, Ogawa M, Mikoshiba K (1997). A novel neurological mutant mouse, yotari, 
which exhibits reeler-like phenotype but expresses CR-50 antigen/reelin. Neurosci 
Res. 29:217-23. 
Zhang G, Assadi AH, McNeil RS, Beffert U, Wynshaw-Boris A, Herz J, 
Clark GD, D'Arcangelo G (2007). The Pafah1b complex interacts with the Reelin 
receptor VLDLR. PLoS ONE. 2:e252.  
Zoghbi HY (2000). Spinocerebellar ataxias. Neurobiol Dis. 7:523-7. 
 86 
PART VI: APPENDICES 
Appendix A: Genome Wide 250K SNP Genotyping Results 
Appendix B: Exclusion of Compound Heterozygosity Possibility in   
           Families B and C 
Parametric Analysis for Recessive_Model
50.0 100.0 150.0 200.0 250.0
Chromosome 1 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0 200.0 250.0
Chromosome 2 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0 200.0
Chromosome 3 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0 200.0
Chromosome 4 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0 200.0
Chromosome 5 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 6 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 7 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 8 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 9 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 10 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 11 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 12 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
40.0 80.0 120.0
Chromosome 13 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
40.0 80.0 120.0
Chromosome 14 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
40.0 80.0 120.0
Chromosome 15 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
40.0 80.0 120.0
Chromosome 16 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
40.0 80.0 120.0
Chromosome 17 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
40.0 80.0 120.0
Chromosome 18 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
20.0 40.0 60.0 80.0 100.0
Chromosome 19 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
20.0 40.0 60.0 80.0 100.0
Chromosome 20 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
20.0 40.0 60.0
Chromosome 21 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
20.0 40.0 60.0
Chromosome 22 Position (cM)
-8.0
-4.0
0.0
4.0
Parametric Analysis for Recessive_Model
50.0 100.0 150.0
Chromosome 24 Position (cM)
-8.0
-4.0
0.0
4.0
Affected Individual in Family B
5’UTR amplified with primer pair 1
Appendix B
Exon 2 amplified with primer pair 3
Exon 3 amplified with primer pair 4
Exon 5 amplified with primer pair 6
Exon 4 amplified with primer pair 5
Exons 5 and 6 amplified with primer pair 7
Exon 7 amplified with primer pair 8
Exon 8 amplified with primer pair 9
Exon 9 amplified with primer pair 10
Exon 10 amplified with primer pair 11
Exon 11 amplified with primer pair 12
Exon 13 amplified with primer pair 14
Exon 12 amplified with primer pair 13
Exon 14 amplified with primer pair 15
Exon 15 amplified with primer pair 16
Exon 16 amplified with primer pair 17
Exon 17 amplified with primer pair 18
Exon 18 amplified with primer pair 19
Exon 19 and 3’UTR amplified with primer pair 20
3’UTR amplified with primer pair 21
3’UTR amplified with primer pair 22
Affected Individual in Family C
5’UTR amplified with primer pair 1
Exon 2 amplified with primer pair 3
Exon 3 amplified with primer pair 4
Exon 5 amplified with primer pair 6
Exon 4 amplified with primer pair 5
Exons 5 and 6 amplified with primer pair 7
Exon 7 amplified with primer pair 8
Exon 8 amplified with primer pair 9
Exon 9 amplified with primer pair 10
Exon 10 amplified with primer pair 11
Exon 11 amplified with primer pair 12
Exon 13 amplified with primer pair 14
Exon 12 amplified with primer pair 13
Exon 14 amplified with primer pair 15
Exon 15 amplified with primer pair 16
Exon 17 amplified with primer pair 18
Exon 18 amplified with primer pair 19
Exon 19 and 3’UTR amplified with primer pair 20
3’UTR amplified with primer pair 21
3’UTR amplified with primer pair 22
3’UTR amplified with primer pair 22
135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PUBLICATIONS 
Mutations in the very low-density lipoprotein
receptor VLDLR cause cerebellar hypoplasia
and quadrupedal locomotion in humans
Tayfun Ozcelik*†‡, Nurten Akarsu§¶, Elif Uz*, Safak Caglayan*, Suleyman Gulsuner*, Onur Emre Onat*, Meliha Tan,
and Uner Tan**
*Department of Molecular Biology and Genetics, Faculty of Science and ‡Institute of Materials Science and Nanotechnology, Bilkent University,
Ankara 06800, Turkey; §Department of Medical Genetics and ¶Gene Mapping Laboratory, Department of Pediatrics, Pediatric Hematology Unit,
Ihsan Dogramaci Children’s Hospital, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey; Department of Neurology,
Baskent University Medical School, Ankara 06490, Turkey; and **Faculty of Sciences, Cukurova University, Adana 01330, Turkey
Edited by Mary-Claire King, University of Washington, Seattle, WA, and approved January 16, 2008 (received for review October 22, 2007)
Quadrupedal gait in humans, also known as Unertan syndrome, is
a rare phenotype associated with dysarthric speech, mental retar-
dation, and varying degrees of cerebrocerebellar hypoplasia. Four
large consanguineous kindreds from Turkey manifest this pheno-
type. In two families (A and D), shared homozygosity among
affected relatives mapped the trait to a 1.3-Mb region of chromo-
some 9p24. This genomic region includes the VLDLR gene, which
encodes the very low-density lipoprotein receptor, a component of
the reelin signaling pathway involved in neuroblast migration in
the cerebral cortex and cerebellum. Sequence analysis of VLDLR
revealed nonsense mutation R257X in family A and single-
nucleotide deletion c2339delT in family D. Both these mutations
are predicted to lead to truncated proteins lacking transmembrane
and signaling domains. In two other families (B and C), the
phenotype is not linked to chromosome 9p. Our data indicate that
mutations in VLDLR impair cerebrocerebellar function, conferring
in these families a dramatic influence on gait, and that hereditary
disorders associated with quadrupedal gait in humans are genet-
ically heterogeneous.
genetics  Unertan syndrome
Obligatory bipedal locomotion and upright posture of mod-ern humans are unique among living primates. Studies of
fossil hominids have contributed significantly to modern under-
standing of the evolution of posture and locomotion (1–5), but
little is known about the underlying molecular pathways for
development of these traits. Evaluation of changes in brain
activity during voluntary walking in normal subjects suggests that
the cerebral cortices controlling motor functions, visual cortex,
basal ganglia, and the cerebellum might be involved in bipedal
locomotor activities (6). The cerebellum is particularly impor-
tant for movement control and plays a critical role in balance and
locomotion (7).
Neurodevelopmental disorders associated with cerebellar hy-
poplasias are rare and often accompanied by additional neuro-
pathology. These clinical phenotypes vary from predominantly
cerebellar syndromes to sensorimotor neuropathology, ophthal-
mological disturbances, involuntary movements, seizures, cog-
nitive dysfunction, skeletal abnormalities, and cutaneous disor-
ders, among others (8). Quadrupedal locomotion was first
reported when Tan (9, 10) described a large consanguineous
family exhibiting Unertan syndrome, an autosomal recessive
neurodevelopmental condition with cerebellar and cortical hy-
poplasia accompanied by mental retardation, primitive and
dysarthric speech, and, most notably, quadrupedal locomotion.
Subsequent homozygosity mapping indicated that the phenotype
of this family was linked to chromosome 17p (11). Thereafter,
three additional families from Turkey (12–14) and another from
Brazil (15) with similar phenotypes have been described, and
video recordings illustrating the quadrupedal gait have been
made (10–12). Here, we report that VLDLR is the gene respon-
sible for the syndrome in two of these four Turkish families and
report additional genemapping studies that indicate the disorder
to be highly genetically heterogeneous.
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Fig. 1. Phenotypic (A) and cranial radiologic (B) presentation of quadrupe-
dal gait in families A and D. (A) Affected brothers VI:20 and VI:18 and cousin
VI:25 in family A (Upper) and the proband II:2 in family D (Lower) display
palmigrate walking. This is different from quadrupedal knuckle-walking of
the great apes (2). The hands make contact with the ground at the ulnar palm,
and consequently this area is heavily callused as exemplified by VI:20. Stra-
bismus was observed in all affected individuals. (B) Coronal and midsagittal
MRI sections of VI:20, demonstrating vermial hypoplasia, with the inferior
vermial portion being completely absent. Inferior cerebellar hypoplasia and a
moderate simplification of the cerebral cortical gyri are noted. The brainstem
and the pons are particularly small (Left and Center). Similar findings are
observed for II:2 (Right).
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Results
The proband of Family A (12) is a 37-year-old male with habitual
quadrupedal gait (Fig. 1A Upper Left and Fig. 2A, VI:20). He did
not make the transition to bipedality during his childhood
despite the efforts of his healthy parents. He has dysarthric
speech with a limited vocabulary, truncal ataxia, and profound
mental retardation. He was not aware of place or of the year,
month, or day. His MRI brain scan revealed inferior cerebellar
and vermial hypoplasia, with the inferior vermial portion being
completely absent. Whereas corpus callosum appeared normal,
a moderate simplification of the cerebral cortical gyri accom-
panied by a particularly small brainstem and the pons was
observed (Fig. 1 B Left andCenter). Subsequently, we studied the
proband’s affected brother and cousin (Fig. 1AUpper Center and
Fig. 2. Homozygosity mapping of cerebellar hypoplasia and quadrupedal locomotion to chromosome 9p24 (A) and identification of the VLDLR c769C 3 T
mutation in family A (B) and of theVLDLR c2339delT mutation in family D (C). (A) Pedigree of family A; filled symbols represent the affected individuals. Squares
indicate males, and circles indicate females. Black bars represent the haplotype coinherited with the quadrupedal phenotype in the family. Recombination events
in individuals VI:16 (obligate carrier) and VII:4 (normal sibling) positioned the disease gene between markers rs7847373 and rs10968723. Physical positions and
pairwise lod scores for each marker are shown on the upper left. Zmax represents the maximum lod score obtained at  0.00 cM. (B and C) Sequences of critical
regions of VLDLR for wild-type and homozygous mutant genotypes.
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Upper Right and Fig. 2A, VI:18 and VI:25) and other branches
of the family living in nearby villages in southeastern Turkey. All
affected individuals were offspring of consanguineous marriages
(Fig. 2A). With the exception of one female (VII:1), who was an
occasional biped with ataxic gait, all affected persons in family
A had quadrupedal locomotion.
The proband of family D (14) is a 38-year-old male (Fig. 1A
Lower Left and Center). Like all other quadrupedal individuals
in these families, he did not make the transition to bipedality
during his early childhood. He is profoundly retarded and
exhibits dysarthric speech along with truncal ataxia. His MRI
brain scan images are consistent with moderate cerebral cortical
simplification and inferior cerebellar and vermial hypoplasia
(Fig. 1BRight). The 65-year-old aunt and 63-year-old uncle of the
proband are both mentally retarded and continue to walk on
their wrists and feet despite their advanced ages. The family is
consanguineous; all relatives were raised in neighboring villages
on the western tip of the Anatolian peninsula.
All patients in these four families had significant developmen-
tal delay noted in infancy (Table 1). They sat unsupported
between 9 and 18months, and began to crawl on hands and knees
or feet. Whereas normal infants make the transition to bipedal
walking in a short period, the affected individuals continued to
move on their palms and feet and never walked upright. All
patients had severe truncal ataxia affecting their walking pat-
terns. They can stand from a sitting position and maintain the
upright position with flexed hips and knees. However, they
virtually never initiate bipedal walking on their own and instead
ambulate efficiently in a quadrupedal fashion. All patients had
hyperactive lower leg and vivid upper extremity reflexes. Normal
tone and power were observed in motor examination. All
affected persons were mentally retarded to the degree that
consciousness of place, time, or other experience appeared to be
absent. However, no autistic features were expressed. The
affected individuals all had good interpersonal skills, were
friendly and curious to visitors, and followed very simple ques-
tions and commands. Additional clinical information on families
A and D is provided in supporting information (SI) Table 2.
To identify the chromosomal locale of the gene or genes
responsible for this phenotype, we carried out genome-wide
linkage analysis and homozygosity mapping in families A–C (see
Materials and Methods below). Although the families lived in
isolated villages 200–300 km apart and reported no ancestral
relationship, the rarity of the quadrupedal gait in humans led us
to expect a single locus shared by affected individuals in all
families. Instead, the trait mapped to three different chromo-
somal locales. In family A, linkage analysis and homozygosity
mapping positioned the critical gene on chromosome 9p24
between rs7847373 and rs10968723 in a 1.032-Mb region (Fig.
2A and SI Fig. 4). In family B, the trait mapped to chromosome
17p13, confirming a previous study (11). In family C, highly
negative logarithm of odds (lod) scores were obtained for both
chromosomes 9p24 and 17p13 (SI Figs. 5 and 6); gene mapping
in this family is ongoing. In family D, polymorphic markers from
the critical intervals of chromosomes 9p24 and 17p13 were
genotyped, and homozygosity was detected with markers on
9p24. Together, these results indicate that the syndrome includ-
ing quadrupedal gait, dysarthric speech, mental retardation, and
cerebrocerebellar hypoplasia is genetically heterogeneous.
The chromosome 9p24 region linked to the trait in families A
and D includes VLDLR, the very low-density lipoprotein recep-
tor. We hypothesized that a gene involved in neural develop-
ment, cell positioning in brain, and cerebellar maturation could
be involved in the pathogenesis of quadrupedal gait. In addition,
cerebellar hypoplasia with cerebral gyral simplification was
shown to be associated with a genomic deletion that includes
VLDLR (16). We therefore considered VLDLR (17) to be a
prime positional candidate for our phenotype and sequenced the
gene in genomic DNA from probands of the four families (SI
Table 3). The VLDLR sequence of affected members of family
A was homozygous for a nonsense mutation in exon 5 (c769C3
T; R257X) (Fig. 2B). The VLDLR sequence of the proband of
family D was homozygous for a single-nucleotide deletion in
exon 17 resulting in a stop codon (c2339delT; I780TfsX3) (Fig.
2C). VLDLR sequences excluded the possibility of compound
heterozygosity in families B and C (SI Fig. 7). In families A and
D, homozygosity for the VLDLR mutations was perfectly coin-
herited with quadrupedal gait (SI Figs. 8 and 9). Both mutations
were absent from 100 unaffected individuals who live in the same
local areas of southeastern and western Turkey as families A and
D (SI Fig. 10).
Table 1. Physical, radiological, and genetic characteristics of the Turkish families in this study and of Hutterite family DES-H (27)
Characteristic Family A Family B Family C Family D DES-H
Chromosomal location 9p24 17p Not 9p or 17p 9p24 9p24
Gene and mutation VLDLR
(c769C3 T)
Unknown Unknown VLDLR
(c2339delT)
Deletion including VLDLR
and LOC401491
Gait Quadrupedal Quadrupedal Quadrupedal Quadrupedal Bipedal
Speech Dysarthric Dysarthric Dysarthric Dysarthric Dysarthric
Hypotonia Absent Absent Absent Absent Present
Barany caloric nystagmus Normal Cvs defect Pvs defect Not done Not done
Mental retardation Profound Severe to profound Profound Profound Moderate to profound
Ambulation Delayed Delayed Delayed Delayed Delayed
Truncal ataxia Severe Severe Severe Severe Severe
Lower leg reflexes Hyperactive Hyperactive Hyperactive Hyperactive Hyperactive
Upper extremity reflexes Vivid Vivid Vivid Vivid Vivid
Tremor Very rare Mild Present Absent Present
Pes-planus Present Present Present Present Present
Seizures Very rare Rare Rare Absent Observed in 40% of cases
Strabismus Present Present Present Present Present
Inferior cerebellum Hypoplasia Hypoplasia Mild hypoplasia Hypoplasia Hypoplasia
Inferior vermis Absent Absent Normal Absent Absent
Cortical gyri Mild simplification Mild simplification Mild simplification Mild simplification Mild simplification
Corpus callosum Normal Reduced Normal Normal Normal
Cvs, central vestibular system; Pvs, peripheral vestibular system.
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VLDLRR257X is in the ligand-binding domain, and
VLDLRI780TfsX3 is in the O-linked sugar domain of the
VLDLR protein (Fig. 3 A and B). Mutant VLDLR transcripts
were expressed in endothelial cells from blood of affected
individuals (Fig. 3C), and in these cells, levels of mutant and
wild-type transcript expression appeared approximately equal
(Fig. 3D; please also see SI Text). Because the stop codons of
both mutations are located in the extracellular domain of
VLDLR (Fig. 3B), the encoded mutant proteins could not be
inserted into the membrane and could not function as receptors
for reelin.
We propose VLDLR-associated Quadrupedal Locomotion
(VLDLR-QL) or Unertan Syndrome Type 1 to describe the
phenotype of families A and D.
Discussion
The identification of these VLDLR mutations provides molec-
ular insight into the pathogenesis of neurodevelopmental move-
ment disorders and expands the scope of diseases caused by
mutations in components of the reelin pathway (18). Reelin is a
secreted glycoprotein that regulates neuronal positioning in
cortical brain structures and the migration of neurons along the
radial glial fiber network by binding to lipoprotein receptors
VLDLR and APOER2 and the adapter protein DAB1 (19). In
the cerebellum, reelin regulates Purkinje cell alignment (20),
which is necessary for the formation of a well defined cortical
plate through which postmitotic granual cells migrate to form the
internal granular layer (21). Homozygous mutations in the reelin
gene (RELN) cause the Norman–Roberts type lissencephaly
syndrome, associated with severe abnormalities of the cerebel-
lum, hippocampus, and brainstem (OMIM 257320) (22). Muta-
tion of Reln in the mouse results in the reeler phenotype and
disrupts neuronal migration in several brain regions and gives
rise to functional deficits such as ataxic gait and trembling (23).
In contrast, mice deficient forVldlr appear neurologically normal
(24), but the cerebellae of these mice are small, with reduced
foliation and heterotopic Purkinje cells (17).
In humans, homozygosity for either of two VLDLR truncating
mutations leads to cerebrocerebellar hypoplasia, specifically
vermial hypoplasia, accompanied by mental retardation, dysar-
thric speech, and quadrupedal gait. In the Hutterite population
of North America, homozygosity for a 199-kb deletion encom-
passing the VLDLR gene leads to a form of Disequilibrium
Syndrome (DES-H, OMIM 224050), characterized by nonpro-
gressive cerebellar hypoplasia with moderate-to-profound men-
tal retardation, cerebral gyral simplification, truncal ataxia, and
delayed ambulation (16). The designation Disequilibrium Syn-
drome was originally given to cerebral palsy characterized by a
variety of congenital abnormalities, including mental retarda-
tion, disturbed equilibrium, severely retarded motor develop-
ment, muscular hypotonia, and perceptual abnormalities (25,
26). Neither DES-H nor other disequilibrium syndromes have
been reported to include quadrupedal gait. The movement of
most DES-H patients was so severely affected that independent
walking was not possible. Those who could walk had a wide-
based, nontandem gait (27).
The neurological phenotypes in the Turkish families and in the
Hutterite families appear similar, with the most striking differ-
ence being the consistent adoption of efficient quadrupedal
locomotion by the affected Turkish individuals (Table 1). In our
view, the movement disorder described for the Hutterite patients
may be a more profound deficit, with the patients perhaps
lacking the motor skills for quadrupedal locomotion. The 199-kb
deletion in DES-H encompasses the entire VLDLR gene and
part of a hypothetical gene. LOC401491, the hypothetical gene,
is an apparently noncoding RNA that shares a CpG island and
likely promoter with VLDLR, and is represented by multiple
alternative transcripts expressed in brain. It has been suggested
that the DES-H phenotype could be the result of deletion of
VLDLR or both VLDLR and the neighboring gene (16).
Fig. 3. Functional domains of VLDLR with positions of the mutations relative to the exons (A), domains (B), and the analysis of VLDLR transcript (C and D).
(A) The gene consists of 19 exons. Arrows indicate the locations of the mutations. (B) VLDLR consists of ligand-binding type repeat (LBTR), epidermal growth
factor repeat (EGFR) I–III, YWTD -propeller (YWTD), O-linked sugar domain (OLSD), transmembrane domain (TD), and cytoplasmic domain (CD) (34)
(www.expasy.org/uniprot/P98155). (C) Restriction-based analysis with HphI revealed the presence of only the mutant (347 bp) and both the mutant and wild type
(396 and 347 bp; please note that the 49-bp fragment is not visible) VLDLR transcripts in patient VI:20 and carrier V:18 (both from family A), respectively. M is
a DNA size marker. (D) Quantitative RT-PCR analysis of VLDLR transcript from peripheral blood samples of all probands in families A and D and controls was
performed. Relative expression ratios were normalized according to the housekeeping gene GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and the
endothelial marker KDR (kinase insert domain receptor). Ct values were calculated from duplicate samples and were converted to linear scale (35). Control
denotes ‘‘VLDLR expression in controls,’’ VLDLR-GAPDH denotes ‘‘VLDLR expression in patients normalized to GAPDH,’’ and finally VLDLR-KDR denotes ‘‘VLDLR
expression in patients normalized to KDR.’’
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It has been suggested that in the Turkish families, lack of
access to proper medical care exacerbated the effects of cere-
bellar hypoplasia, leading to quadrupedality. Although it may be
true that family B lacked proper medical care, families A and D
had consistent access to medical attention, and both families
actively sought a correction of quadrupedal locomotion in their
affected children. An unaffected individual in family A is a
physician who was actively involved in the medical interventions.
In family D, the proband’s mother sought a definitive diagnosis
and correction of the proband’s quadrupedal locomotion from
private medical practices and from two major academic medical
centers. The parents in family A discouraged quadrupedal
walking of their affected children, but without success. We
conclude that social factors were highly unlikely to contribute to
the quadrupedal locomotion of the affected individuals.
In conclusion, we suggest that VLDLR-deficiency in the brain
at a key stage of development leads to abnormal formation of the
neural structures that are critical for gait. Given the heteroge-
neity of causes of quadrupedal gait, identification of the genes in
families B and C promises to offer insights into neurodevelop-
mental mechanisms mediating gait in humans.
Materials and Methods
Study Subjects. Parents of patients and other unaffected individuals gave
consent to the study by signing the informed consent forms prepared accord-
ing to the guidelines of the Ministry of Health in Turkey. The Ethics Commit-
tees of Baskent and Cukurova Universities approved the study (decision
KA07/47, 02.04.2007 and 21/3, 08.11.2005, respectively).
Genome-Wide Linkage Analysis. Linkage analysis was performed by SNP geno-
typing with the commercial release of the GeneChip 250K (NspI digest) or 10K
Affymetrix arrays as described (28). In addition, genotype data were analyzed
by hand to identify regions of homozygosity. The parametric component of
the Merlin package v1.01 was used for the multipoint linkage analysis assum-
ing autosomal recessive mode of inheritance with full penetrance (29, 30). The
analysis was carried out along a grid of locations equally spaced at 1 cM.
Haplotype analysis was performed on chromosomal regions with positive lod
scores (Fig. 2A and SI Figs. 4–6). Pairwise linkage was analyzed by using the
MLINK component of the LINKAGE program (FASTLINK, version 3) (31–33).
Markers D17S1298 (3.51 Mb) and D9S1779 (0.4 Mb), D9S1871 (3.7 Mb) were
used to test for homozygosity to chromosomes 17p13 and 9p24, respectively.
Mutation Search. Sequencing primers were designed for each VLDLR exon by
using Primer3, BLAST, and the sequence of NC000009. DNA from all of the
probands was sequenced in both directions by using standard methods. The
mutations in exons 5 (c769C 3 T) and 17 (c2339delT) were detected in all
affected (homozygous) and carrier (heterozygous) individuals of families A
and D, respectively. The c769C3 T mutation creates a restriction site for the
enzyme HphI (5-GGTGA(N)82 3), and the c2339delT mutation abolishes a
restriction site for the enzyme MboI (5-G2 ATC-3). Assays using these
restriction enzymes were developed to test for the mutations in all four
families and in 200 healthy controls from the Turkish population. Restriction
based mutation and quantitative RT-PCR analyses of VLDLR transcript in
patients and controls was also performed (please see SI Text relating to Fig. 3
C and D).
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LETTER
Reply to Herz et al. and Humphrey
et al.: Genetic heterogeneity of
cerebellar hypoplasia with
quadrupedal locomotion
Mutations in the very low-density lipoprotein receptor
VLDLR are responsible for cerebellar hypoplasia with qua-
drupedal gait (1). The most likely mechanism leading to this
phenotype is that VLDLR deficiency in the brain at a key
stage of development precludes the normal formation of neu-
ral structures critical for gait. Quadrupedal gait is an integral
part of VLDLR-associated cerebellar hypoplasia syndrome in
these families (1, 2). It is not necessary to invoke an ‘‘epiphe-
nomenon’’ or ‘‘unfavorable environmental conditions’’ to ex-
plain the phenotype (3), but rather simply considering clinical
heterogeneity in the context of genomic understanding of
complex traits is sufficient.
Disequilibrium syndrome was first described by the Swedish
neuropediatrician Bengt Hagberg and colleagues (4) as a
form of cerebral palsy characterized by a variety of congenital
abnormalities. Subsequently, Schurig et al. (5) described, in
the North American Hutterite population, inherited cerebellar
disorder with mental retardation, the genetic basis of which
proved to be homozygous deletion of the VLDLR gene and
the adjacent noncoding LOC401491 sequence (6). Based on
the phenotypic similarities of the Swedish and Hutterite pa-
tients, the acronym DES-H [disequilibrium syndrome-
Hutterites, Online Mendelian Inheritance in Man (OMIM)
accession no. 224050] was adopted for this syndrome (6).
Our results (1) and those of others (7) extend these find-
ings to different VLDLR mutations leading to cerebellar hyp-
oplasia and related disequilibrium features, including in some
families bipedal gait (5, 6), in other families quadrupedal gait
(1, 8), and in another family ‘‘gait ataxia’’ (7). Additional kin-
dreds with disequilibrium syndrome and quadrupedal gait
have been described in Brazil (9) and Iraq (10). It will be in-
teresting to know whether mutations responsible for the phe-
notype in these families lie in the VLDLR gene or in one
of the other loci linked to this genetically heterogeneous
phenotype (1).
The comments of Humphrey et al. (11) address three fun-
damental features of genomic analysis of human traits: allelic
heterogeneity, genotype–phenotype correlations, and variable
expression.
Allelic heterogeneity—the expression of the same pheno-
type due to different mutations in a gene—is characteristic of
virtually all human genetic disease. For example, homozygos-
ity for any of 300 different mutations in the LDL receptor
leads to hypercholesterolemia. It was to be expected, there-
fore, that in different families different mutations in VLDLR
would lead to a phenotype comprising cerebellar hypoplasia
with quadrupedal gait. It would not be expected that quadru-
pedalism would be present only in the presence of one ‘‘spe-
cific mutation.’’
The converse observation, of a correlation between geno-
type and phenotype, is also characteristic of inherited human
disease. Different mutations in the same gene frequently lead
to different clinical phenotypes. Contrary to the statement of
Humphrey et al. (11), the Hutterite families in North America
and families A and D in Turkey do not carry ‘‘the same ho-
mozygous mutation.’’ The Hutterite mutation is a complete
genomic deletion of VLDLR; the mutations in Turkish fami-
lies A and D are, respectively, a nonsense mutation and a
single-base-pair deletion leading to a frame shift in VLDLR.
It is not surprising, therefore, that features of the cerebellar
hypoplasia syndrome, including presence or absence of qua-
drupedal walking, differ among families with different muta-
tions in the gene.
Third, variable expression of a phenotype is frequently ob-
served even among persons with the same mutation in a criti-
cal gene. Variable expression may be due to differences in
genetic background of the individual, to differences in envi-
ronmental exposures, or to chance. Among affected individu-
als in families A and D, none displays exclusively bipedal
locomotion; two affected individuals can walk bipedally for
short distances but prefer quadrupedal locomotion (1, 8).
Finally, the use of a walking frame to assist bipedalism in
affected individuals (12) does not demonstrate that the cause
of quadrupedalism was ‘‘local cultural environment.’’ Wear-
ing eyeglasses assists persons with myopia. Should we then
conclude that near-sightedness is caused by ‘‘local cultural
environment’’?
Some descriptions by the press of Turkish families with cer-
ebellar hypoplasia and quadrupedal gait have portrayed the
affected individuals as doomed to quadrupedal gait by the
religious beliefs of their parents (13). We hope that future
descriptions of these families will conform to standards re-
f lected in recent genomic analyses of their disorder.
Tayfun Ozcelik*†‡, Nurten Akarsu§¶, Elif Uz*, Safak Caglayan*,
Suleyman Gulsuner*, Onur Emre Onat*, Meliha Tan, and
Uner Tan**
*Department of Molecular Biology and Genetics, Faculty of Sci-
ence, and †Institute of Materials Science and Nanotechnology,
Bilkent University, Ankara 06800, Turkey; §Department of Medical
Genetics and ¶Gene Mapping Laboratory, Department of Pediat-
rics, Pediatric Hematology Unit, Ihsan Dogramaci Children’s
Hospital, Hacettepe University Faculty of Medicine, Ankara 06100,
Turkey; Department of Neurology, Baskent University Medical
School, Ankara 06490, Turkey; and **Faculty of Sciences, Cuku-
rova University, Adana 01330, Turkey
1. Ozcelik T, et al. (2008) Mutations in the very low-density lipoprotein receptor VLDLR cause
cerebellar hypoplasia and quadrupedal locomotion in humans. Proc Natl Acad Sci USA
105:4232–4236.
2. Tan U (2005) A new theory on the evolution of human mind. Unertan syndrome: Quadrupe-
dality, primitive language, and severe mental retardation.NeuroQuantology 4:250–255.
3. Herz J, Boycott KM, Parboosingh JS (2008) ‘‘Devolution’’ of bipedality. Proc Natl Acad
Sci USA 105:E25.
4. Hagberg B, Scanner G, Steen M (1972) The dysequilibrium syndrome in cerebral palsy.
Clinical aspects of treatment. Acta Paediatr Scand 61(Suppl 226):1–63.
5. Schurig V, Van Orman A, Bowen P (1981) Nonprogressive cerebellar disorder with mental
retardation and autosomal recessive inheritance in Hutterites. Am JMed Genet 9:43–53.
E32–E33  PNAS  June 10, 2008  vol. 105  no. 23 www.pnas.orgcgidoi10.1073pnas.0804078105
6. Boycott KM, et al. (2005) Homozygous deletion of the very low density lipoprotein
receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral
simplification. Am J Hum Genet 77:477–483.
7. Moheb LA, et al. (2008) Identification of a nonsense mutation in the very low-density
lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome.
Eur J Hum Genet 16:270–273.
8. Turkmen S, et al. (March 26, 2008) Cerebellar hypoplasia, with quadrupedal locomo-
tion, caused by mutations in the very low-density lipoprotein receptor gene. Eur J Hum
Genet, 10.1038/ejhg.2008.73.
9. Garcias GL, Roth MG (2007) A Brazilian family with quadrupedal gait, severe mental
retardation, coarse facial characteristics, and hirsutism. Int J Neurosci 117:
927–933.
10. Fletcher M (October 17, 2007) Life on all fours. Times Online. Available at www.time-
sonline.co.uk/tol/lifeandstyle/health/article2671426.ece.
11. Humphrey N, Mundlos S, Turkmen S (2008) Genes and quadrupedal locomotion in
humans. Proc Natl Acad Sci USA 105:E26.
12. Harrison J, Holt S (2006) The Family That Walks on All Fours (BBC, London).
13. Ahuja A (2007) We’re all made with quadrupedal walking ability. TimesOnline. Available
at http://women.timesonline.co.uk/tol/lifeandstyle/women/thewaywelive/
article2671044.ece.
Author contributions: T.O., N.A., E.U., S.C., S.G., O.E.O., M.T., and U.T. wrote the paper.
The authors declare no conflict of interest.
‡To whom correspondence should be addressed. E-mail: tozcelik@bilkent.edu.tr.
© 2008 by The National Academy of Sciences of the USA
Ozcelik et al. PNAS  June 10, 2008  vol. 105  no. 23  E33
